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Oncology nurses are at risk for moral distress when providing routine care.  Nurses have 
reported barriers in delivering optimal pain relief and distress when giving chemotherapy to 
patients that are seriously ill.  Although this situation can escalate moral distress in the nurse, 
some nurses have become stronger advocates for their patients.  Moral distress is described as a 
perceived threat to one’s values or identity that can inhibit the individual from pursuing the right 
course of action.  As such, nurses who experience high levels of moral distress and repeated 
encounters may be more likely to have moral distress residue and leave a current position for one 
less stressful.  Moral distress residue is cumulative or unresolved distress.  How nurses take a 
stand or demonstrate moral courage during times of distress is not well understood.  Therefore, 
this study was undertaken to examine relationships between moral distress, moral distress 
residue, and moral courage and to identify nurse characteristics that were predictors of moral 
distress and moral courage.  For this mixed method, non-experimental correlation design, 
qualitative methods were used to expand quantitative results.  Oncology nurses (n=187) working 
in inpatient and outpatient settings were recruited through the National Oncology Nursing 
Society in the Southeastern United States.  Hamric’s 21-item Moral Distress Scale-Revised 
(MDS-R) and Sekerka et al. 15-item Professional Moral Courage Scale were used for data 
collection.  Findings from this study show that work setting and having left a previous job were 
predictors of moral distress but total years’ experience in oncology was predictive of moral 
courage.  Moral courage was displayed in major areas of supporting the patient, risk taking, 
advocacy, enlarging the circle for decision-making, putting aside personal beliefs, respecting 
patient autonomy, empowering the patient, fighting for the patient in the face of consequences in 
iv 
 
a complex system, sharing information, getting to the meaning, handling tricky situations, 
protecting the patient and truth-telling.  Despite experiencing levels of moral distress, oncology 
nurses demonstrate support and respect for patients’ decision-making and autonomy.   Ethics 
education derived from clinical practice can provide an opportunity for open discussion for 
nurses to create and maintain morally acceptable work environments that enable them to be 
morally courageous.   This research underscores the presence of moral distress and moral distress 
residue among oncology nurses and the importance of finding ways to lessen moral distress and 
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CHAPTER ONE: INTRODUCTION 
 
Background 
Oncology nurses play a fundamental role in caring for people with cancer (Ferrell & 
Coyle, 2008).  The relief of suffering is at the core of caring, and oncology nurses alleviate 
suffering by means of a caring relationship, empowering patients and supporting the 
patient/family connection throughout cancer treatment (Iranmanesh, Axelsson, Savenstedt, & 
Haggstrom, 2009).  Nurses in oncology strive to relieve pain, maintain open and honest 
communication, and collaborate substantially to improve patient-outcomes (Pavlish, Brown-
Saltzman, Jakel, & Fine, 2014).  Medicare reimbursement patterns in the last few weeks of a 
patient’s life show that many cancer patients receive high-intensity treatments despite facing a 
terminal disease and poor prognosis (Morden et al., 2012).  Medicare reimburses all aspects of 
cancer care such as paying separately for physician services, laboratory tests, procedures, 
imaging, radiation, drug administration and hospital admissions for adverse outcomes (Bach, 
2007).  The high costs of new chemotherapy drugs and provider incentives that have favored 
aggressive and costly treatments rather than alternative approaches may be driving this pattern 
(Bach, 2007; Miller, 2015).  
Many factors contribute to the patterns that affect the cost of cancer care, including 
patient, family or provider preferences and opportunities exist to reduce spending that do not 
involve denying patients access to life-saving treatments (Miller, 2007).  Deciding when to stop 
chemotherapy can be challenging because both patients and providers may think that ending 
2 
 
treatment is the same as giving up hope or abandoning the patient (Buiting, Rurup, Wijsbek, van 
Zuylen, & den Hartogh, 2011).  However, a different problem occurs when a patient’s preference 
for care does not align with the goals of therapy.  Nurses are often caught in the middle of this 
conflict and experience moral distress when patients, families, and the medical team disagree 
about treatment (Ferrell & Coyle, 2008).  An association exists between nurses’ own suffering 
and the suffering witnessed in their patients (Ferrell & Coyle, 2008).  When the patient’s 
autonomy and preference for care conflicts with the goals of members of the treatment team, 
oncology nurses are usually the first to know and may become distressed if their efforts to 
advocate for and alleviate pain and suffering are perceived as ineffective in the treatment plan.  
Another factor that may promote moral distress rather than moral courage is a perceived power 
imbalance between physicians and nurses that may make it difficult for a nurse to take a stand 
against futile treatment.  For example, when power imbalances exist, a nurse may feel that she 
cannot exercise autonomy or contribute to clinical decision-making which can have a negative 
impact on patient outcome (Kim, Nicotera, McNulty, 2015; Papathanassoglou, Karanikola, 
Kalafati, Giannakopoulou et al., 2012).   
The oncology setting is the most cited with regards to nurses’ suffering associated with 
cancer pain and death (Ferrell & Coyle, 2008).  Nurses are at risk for moral distress when they 
encounter barriers to what they perceive as optimal patient outcomes, such as minimizing harm 
to patients or providing adequate pain control and good end-of-life care (Bernhofer & Sorrell, 
2014; Corley, 2002; LeBaron, Beck, Black, & Palat, 2014).  Moral distress is described as a 
perceived threat to one’s core values or identity that inhibits the individual from taking the right 
course of action (Corley, 2002; Epstein & Hamric, 2009; Jameton, 1984).  Nurses who have 
frequent encounters with morally challenging situations where they are not able to take their 
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perceived morally right action may have higher levels of distress.  Nurses who are not able to 
alleviate the distress may have cumulative effects or moral distress residue (Hamric, 2012).  
Studies have shown that higher levels of moral distress or moral residue were present in nurses 
who left a job or considered leaving a previous job (Hamric, 2012).  Thus, having left a job or 
considered leaving a previous job due to moral distress is an indirect or proxy indication of moral 
distress residue (A.B. Hamric, personal communication, November 9, 2014).  Moral distress 
residue is the residual effect of compromising one’s perceived moral or ethical duty (Epstein & 
Hamric, 2009; Jameton, 1993; Webster & Bayliss, 2000).   
Study findings on moral distress have shown nurses’ weakness and suffering (Ferrell, 
2006; Gutierrez, 2005), but how nurses elicit inner strength or moral courage during times of 
distress has not been investigated.  Moral courage is needed to take moral action so that nurses 
can uphold their moral duty and accept moral challenges with integrity (Sekerka, Bagozzi, & 
Charnigo, 2009).  While previous studies have examined moral distress in nurses, the 
relationship between moral distress and moral courage in oncology nurses working in the adult 
oncology inpatient and outpatient settings has not been studied.  The conceptual framework was 
proposed to guide the study and to examine the relationship between moral distress, moral 
distress residue, and moral courage.   
The frequency with which nurses encounter morally challenging situations and barriers to 
optimal patient care could be the catalyst for moral distress (Corley, 2002) or moral courage.  
Studies have reported high levels of moral distress in nurses who witness the delivery of 
medically ineffective interventions (Elpern, Covert, & Kleinpell, 2005; Ferrell, 2006; Gutierrez, 
2005; Maningo-Salinas, 2010; Sirilla, 2014).  An intervention can be perceived as medically 
futile when its goals are not attainable or the degree of success is suboptimal and prolongs the 
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dying process rather than restoring health (Coppa, 1996; Meltzer & Huckabay, 2004; Mobley, 
Rady, Verheijde, Patel, & Larson, 2007).  Nurses who provide what they perceive as overly 
aggressive treatments near end-of-life may consciously object and silently suffer in such care 
(Ferrell, 2006; Hamric & Blackhall, 2007; Wiegand & Funk, 2012) or they may take a moral 
stand.  According to a study by Gutierrez (2005), nurses in a critical care unit did not want to be 
assigned to the care of a patient whose medical situation they judged to be overly aggressive and 
medically futile.  Nurses with high moral distress levels also reported physical and emotional 
symptoms, avoidance behavior, and fewer interactions and communication with providers, 
patients and family (DeVillers, & DeVon, 2012; Elpern, Covert, & Kleinpell, 2005; Gutierrez, 
2005; LeBaron, Beck, Black, & Palat, 2014).   
Physical symptoms associated with moral distress in nurses included insomnia, 
headaches, and stomach aches (Ferrell, 2006; Gutierrez, 2005; McClendon & Buckner, 2007; 
Wiegand & Funk, 2012).  Emotional symptoms included stress, anxiety, guilt, frustration, and 
burnout (Gutierrez, 2005; McClendon & Buckner, 2007).  Consequently, moral distress has the 
potential to alter the quality of care and impact patient safety (Austin, 2012; Gutierrez, 2005; 
Maiden, Georges, & Connelly, 2011; Wiegand & Funk, 2012).  The negative consequences of 
nurses’ moral distress have not been evaluated in patients or families, but nurses have perceived 
indirect consequences such as fewer interactions and delayed care to the patients and families 
(Gutierrez, 2005; Rice et al., 2008; Wiegand & Funk, 2012). 
The literature on moral distress presents barriers to taking action when moral distress 
occurs and introduces strategies for reducing moral distress (American Association of Critical 
Care Nurses, 2006).  However, missing from the literature is whether ethics education has been 
effective in reducing moral distress and how nurses take a stand to assume their moral challenges 
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with integrity.  Moral courage is described as the capacity to overcome fear by standing up for 
one’s core values, and disposition to speak out or to take action in an assertive and principled 
manner (Lachman, 2007a, Simola, 2014).  The extent to which moral courage is cultivated and 
exercised could strengthen moral judgment and action (Simola, 2014) thus alleviating moral 
distress.  Moral courage is essential to decreasing moral distress in the nursing profession 
(Gallaher, 2011; Lachman, 2010; Murray, 2010).  While ample studies have examined moral 
distress in nurses (Elpern, Covert, & Kleinpell, 2005; Hamric & Blackhall, 2007; Lazzarin, 
Biondi, & DiMauro, 2012; Sirilla, 2014), moral courage remains elusive.  Within the field of 
business ethics, moral courage is an important construct applicable to practices leading to ethical 
action and specific types of ethical situations (Simola, 2014).  Although a framework was 
introduced for moral courage for nurses, (Lachman, 2010; LaSala & Bjarnason, 2010; Simola, 
2014), it has not been tested and the relationships between moral distress and moral courage are 
not clear.  Qualitative studies for moral courage are scarce and a few anecdotal reports and case 
studies have suggested strategies or activities to support moral courage, but such strategies have 
not been tested (Lachman, 2007b; Lachman, 2010; LaSala, 2010; Murray, 2010).  The literature 
on moral distress has described nurses as strong patient advocates (Ferrell, 2006; Gutierrez, 
2005).  Whether or not nurses take action in specific moral challenges has not been quantifiable.  
A few researchers investigated moral distress in oncology nurses, yet none of those 
studies examined the relationship between moral distress and moral courage.  The oncology 
literature indicates that oncology nurses are observers of both the benefits and burdens of 
chemotherapies (Ferrell, 2006; Hamric & Blackhall, 2007; Rice, Rady, Hamrick, Verheijde, & 
Pendergast, 2008; Shepard, 2010) suggesting that the oncology nurse’s experience is an 
emotionally and morally sensitive one with repeated exposure to moral challenges (Cohen & 
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Erickson, 2006; LeBaron, Beck, Black, & Palat, 2014).  Therefore, identifying which oncology 
nurse characteristics are predictors of moral distress and moral courage can increase 
understanding and provide context specific content to enhance the development of interventions 
that lessen moral distress while supporting moral courage.  Besides, understanding which nurse 
actions exemplify morally courageous actions taken by these nurses can lead to methods to better 
measure this phenomenon in the future.  Because oncology nurses bear witness to suffering and 
many moral conflicts (Cohen & Erickson, 2006), their experience provides them a chance to 
bring an important voice in contributing to this body of research.   
Statement of the Problem 
Oncology nurses are fundamental to the care of those who have cancer.  When oncology 
nurses become morally distressed it is because they feel that their efforts to advocate for and 
alleviate pain are not aligned with the patients’ treatment preferences or with treatments nurses 
feel patients should be receiving.  Nurses who reported frequent encounters of moral distress and 
who are not able to resolve their distress may have moral distress residue.  Nurses with repeated 
exposure to distressing situations are likely to have higher moral distress, which can lead to 
moral distress residue and to nurses leaving their current positions.  Moral distress residue is the 
cumulative effect occurring after a morally distressing clinical situation whereby the nurse’s 
moral or ethical duty is compromised.  Moral distress can lead to negative physical symptoms for 
nurses and can alter the quality of care for patients, creating safety concerns as a result of 
delayed care and decreased interactions with patients and their families.  Ethical work 
environments that nurture moral courage can potentially diminish these problems.  
7 
 
Purpose of Study 
The purpose of this study was twofold: (1) to investigate the relationship between moral 
distress, moral distress residue, and moral courage in oncology nurses working in the adult 
inpatient and outpatient settings, and (2) to identify oncology nurse predictors of moral distress 
and moral courage, and specifically, oncology nurse actions that show moral courage.  Data were 
collected using the Moral Distress Scale-Revised (MDS-R) to measure moral distress and moral 
residue, and the Professional Moral Courage Scale to measure moral courage.  One open-ended 
question was posed to obtain a more thorough understanding of the specific source of moral 
distress and actions that demonstrate moral courage.  
Research Questions 
The major research questions asked in this study were: 
1) Is there a difference between oncology nurses in adult inpatient and outpatient settings 
with respect to their moral distress and moral courage?  
2) Among oncology nurses, to what extent, if any, are moral distress and moral courage 
related?  
3) What is the level of moral distress as reported by oncology nurses who report moral 
distress residue described as having left a previous job, considered leaving a previous job 
but stayed, or considering leaving a current job now?  
4) Which of the following nurse characteristics (education level, total number of years 
working as registered nurse, total number of years working as oncology nurse, oncology 
setting, oncology certification, ELNEC education, ethics education, and participation in 
ethics consult) are significant predictors of Moral Distress in oncology nurses? 
8 
 
5) Which of the following nurse characteristics (education level, total number of years 
working as registered nurse, total number of years working as oncology nurse, oncology 
setting, oncology certification, ELNEC education, ethics education, and participation in 
ethics consults) are significant predictors of Professional Moral Courage in oncology 
nurses? 
6) What actions are indicative of moral courage?  Specifically, if you experienced a morally 
challenging situation, describe how you took a stand for your patient; what influenced or 
inhibited your action?  What was the outcome of your stand?  How did that make you 
feel?  
Significance of the Study 
The qualitative and quantitative studies on moral distress have mainly focused on nurses 
in the critical care setting (Browning, 2013; Gutierrez, 2005; Hamric & Blackhall, 2007; 
Meltzer, & Huckabay, 2004; Mobley, Rady, Verheijde, Patel, & Larson, 2007; Wiegand & Funk, 
2012).  These studies showed that nurses experienced a variety of symptoms such as frustration, 
anger, anxiety, and burnout, associated with providing medically futile treatments to patients that 
did not improve outcomes at the patients’ end of life (Corley, Elswick, Gorman, & Clor, 2001; 
Gutierrez, 2005; Meltzer, & Huckabay, 2004;Wiegand & Funk, 2012).  Anecdotal reports 
suggest that oncology nurses witness firsthand the conflicts arising from the delivery of 
aggressive treatments to patients with terminal cancer and poor prognoses (Shepard, 2010).  
Delivering aggressive interventions may generate moral distress for some nurses when they 
perceive that their actions do not align with patient preferences or infringe upon an ethical duty 
to prevent or minimize harm (Shepard, 2010).  In general, ethical decision-making involves a 
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hierarchy of principles whereby nurses are taught to support patient self-determination and a 
duty to honor in any situation (ANA, 2015).  Learning how oncology nurses internalize these 
ethical principles to take a moral stand expands the current literature.  Oncology nurses have 
expressed challenges in 1) giving treatments that cause suffering, 2) being honest without taking 
away hope, and 3) speaking out to prevent further distress (Pavlish, Brown-Saltzman, Jakel, & 
Fine, 2014).  Moral distress can arise when patients’ autonomy and decision making are 
disregarded whereby the nurse’s core values include promoting, advocating for, and protecting 
the health, safety and rights of the patient (ANA, 2015; Cohen & Erickson, 2006).  The 
compromised value could have unfavorable consequences that diminish the nurses’ moral 
dimensions of caring and could prevent them from being full partners in healthcare (Hamric, 
2012).  Being a full partner in healthcare requires that the nurse recognize moral distress and act 
courageously and professionally to address morally distressing clinical situations (Institute of 
Medicine, 2011; Pendry, 2007).  
Nurses are important human capital within healthcare organizations.  A nurse’s 
resignation emanating from moral distress and moral distress residue can have overwhelming 
implications for patient safety and the quality of care.  The implications can have a ripple effect 
on patient satisfaction and the organization's mission and goals (American Association of 
College of Nursing, 2012; Devillers & DeVon, 2012; Pendry, 2007).  Consequently, a study that 
examines the relationship between moral distress, moral distress residue, and moral courage in 
oncology nurses, in adult inpatient and outpatient settings, adds to existing knowledge and 
expands the science on moral distress and moral courage.  This study also gives important 
perspectives from oncology nurses on moral courage and underscores the importance of 
supporting positive work environments, preserving nurse integrity, and improving nurse 
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retention in oncology nurses.  This study was particularly important because a primary focus was 
to understand the relationships between moral distress, moral distress residue, and moral 
courage. 
Organization of the Remainder of the Study 
Chapter two contains the conceptual framework model, definitions, and synthesis of 
relevant literature and identification of gaps in research on moral distress. Chapter three 
describes the methodology and procedures used to gather data for the study. Chapter four 





CHAPTER TWO: REVIEW OF RELEVANT LITERATURE AND 
FRAMEWORK  
 
The chapter is divided into sections that include (a) the theoretical and conceptual 
framework, (b) key definitions of variables (c) literature review of relevant research and 
synthesis, (d) identification of gaps in the literature, and (e) summary. 
Theoretical Framework and Conceptual Model 
This study proposed an integrated conceptual framework (Figure 1) for investigating 
moral distress, moral residue and moral courage in oncology nurses as moral agents.  The basic 
elements of the framework include moral challenges, nurse characteristics (i.e., age, education, 
years of work experience, years of oncology nurse experience, work setting, ethics education, 
end of life education, oncology certification), moral action of the nurse, moral courage, moral 
distress, and moral residue (Corley, 2002; Elpern, Covert, & Kleinpell, 2005; Hamric, Borchers, 
& Epstein, 2012; Lachman, Murray, Iseminger, & Ganske, 2012; Meltzer & Huckabay, 2004; 
Mobley, Rady, Verheijde, Patel, & Larson, 2007; Pavlish, Brown-Saltzman, Jakel, & Fine, 
2014).  The oncology nurse as a moral agent is expected to incorporate professional and personal 
values, drawing upon the nursing code of ethics, in the decision-making process to effectively 
sort out what action should be taken (American Nurses Association, 2015; Hamric, 1999).  
Moral challenges that stem from internal or external sources can act as the catalyst to generate 
moral distress and moral courage (Corley, 2002; Hamric, Borchers, & Epstein, 2012; Sekerka, 
Bagozzi, & Charnigo, 2009).  The nurse as a moral agent must manage emotions, and balance 
the desire to proceed with the moral action against competing threats or challenges (Sekerka, 
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Bagozzi, & Charnigo, 2009).  Nurses who manage emotions take the morally correct action and 
demonstrate moral courage.  Nurses who feel constrained or are unable to manage emotions and 
take the moral action may demonstrate moral distress (Epstein, & Hamric, 2009).  The frequency 
and intensity of the moral challenge is associated with high levels of moral distress (Corley, 
2002; Epstein, & Hamric, 2009).  The cumulative or unresolved moral distress is indicative of 
moral distress residue (Epstein, & Hamric, 2009; Hamric, Borchers, & Epstein, 2012).  
 
Figure 1.  Integrated model of moral distress, moral distress residue and moral courage. 
The moral challenges specified in Figure 1 act as the stimuli to influence the moral action 
of the nurse generating moral distress or moral courage.  Repeated encounters with the stimuli 
and unresolved or cumulative moral distress are associated with moral distress residue (Epstein, 
& Hamric, 2009).  Each of the constructs associated within the framework are discussed in the 
literature review section.  
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Definition of Key Variables 
The following definitions will ensure uniformity and understanding of the terms used 
throughout this study: 
• Moral action – relates to the “do” part of moral decision-making (Cox, 2008) with 
respect to nurses’ obligation regarding principles of beneficence or doing good; non-
maleficence or doing no harm; justice or treating people fairly; reparations or making 
amends for harm; fidelity and respect for all persons (Code of Ethics, ANA, 2015). 
• Moral agent - an individual or nurse with a duty to advocate for and to protect the rights 
of the patient whereby, the nurse articulates nursing values and maintains the integrity of 
the profession and its practice by striving toward moral action (American Nurses 
Association, 2001).   
• Moral challenges – issues/concerns that stem from conflict between the patient, family 
and healthcare team. The conflict can come from internal or external sources, which can 
either inhibit or influence the nurse to take moral action leading to moral distress or 
moral courage (American Association of Critical Care Nurses, 2006; Jameton, 1993).  
Moral challenges have been identified as an antecedent of moral distress and moral 
courage (Epstein & Hamric, 2009). 
• Moral distress – a perceived threat to one’s core values or identity that can inhibit the 
individual from taking the right course of action (Corley, 2002; Epstein & Hamric, 2009; 
Hamric, Borchers, & Epstein, 2012; Jameton, 1984).  
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• Moral courage – the capacity to overcome fear and stand up for one’s core values and 
willingness to speak out or take action in an assertive and principled manner (Lachman, 
2007a). 
• Moral residue or moral distress residue – the result of repeated encounters and 
unresolved or cumulative morally challenging situations associated with moral distress 
(Corley, 2002) that can lead to nurse resignation or intention to leave as a result of 
compromising one’s perceived moral obligation (Epstein & Hamric, 2009; Hamric, 2012; 
Webster & Baylis, 2000).   
• Nurse characteristics – demographic variables measured in this study such as age, level 
of education, years of work experience, years of oncology nurse experience, ethics 
education, end-of-life education, and oncology certification.  
• Nurse resignation – a particular situation that causes the nurse to voluntarily leave the 
job, not exclusive to moral distress but may be indicative of moral residue (Hamric, 
Borchers, & Epstein, 2012; Mohr, Burgess, & Young, 2008).  
• Oncology nurse - a registered professional nurse or advanced practice nurse with 
specialty education in the care of cancer patients (Oncology Nurses Society). 
Literature Review 
Moral distress is a serious concern affecting nurses and other healthcare professionals 
(Allen, Judkins-Cohn, deVelasco, Forges, et al., 2013; Gutierrez, 2005; Hamric & Blackhall, 
2007; Whitehead, Herbertson, Hamric, Epstein, & Fisher, 2015).  Both qualitative and 
quantitative studies have identified sources of moral distress and its potential physical and 
emotional harms to nurses (Gutierrez, 2005; Ferrell, 2006; Meltzer & Huckabay, 2004; Sirilla, 
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2014; Wiegand & Funk, 2012).  For example, manifestations of moral distress included anger, 
frustration, guilt, loss of self-worth, depression, nightmares, insomnia, suffering, resentment, 
sorrow, anxiety, helplessness, powerlessness and burnout (Corley, 2002; Elpern, Covert, and 
Kleinpell, 2005; Ferrell, 2006; Gutierrez, 2005; Meltzer & Huckabay, 2005; Wiegand & Funk, 
2012).  In an effort to examine the relationships between moral distress, ethical environment, 
collaboration, and satisfaction with the quality of care, Hamric and Blackhall (2007) recruited a 
convenience sample of nurses (n=196) and physicians (n=29) working in the critical care units 
from two hospitals in the Southeastern United States.  Moral distress patterns were similar for 
both nurses and physicians.  The most distressing situations involved feeling pressured to 
continue aggressive treatment when such treatment was perceived to not be beneficial (Allen et 
al., 2013; Hamric & Blackhall, 2007).  Nurses often experience difficulties and feel ill-equipped 
and powerless during interactions with these patients (Blomberg, Hylander & Tornkvist, 2008; 
Epstein & Delgado, 2010).  However, nurses perceived these situations as occurring more 
frequently than did physicians (Allen et al., 2013; Hamric & Blackhall, 2007).  
Moral challenges can come from a variety of situations that stem from conflict between 
the patient, family, proxy decision makers, and healthcare team (Pavlish, Brown-Saltzman, Jakel, 
& Fine, 2014).  Nurses are likely to respond to situations that generate suffering and conflict with 
patient goals and preferences, whereby the nurse either takes the moral action or is inhibited 
from acting in a morally congruent manner.  Particularly, moral challenges and perceived 
powerlessness could undermine the nurses’ integrity in taking action or inhibit moral courage 
(American Association of Critical Care Nurses, 2006; Jameton, 1993).  Moral challenges have 
been identified as precursors of moral distress (Epstein & Hamric, 2009) and moral courage 
(Sekerka, Bagozzi, & Charnigo, 2009).  The challenges are reinforced by internal and external 
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influences.  Internal influences include powerlessness, lack of assertiveness or ability to speak up 
in a challenging situation, inability to identify moral concerns (Hamric, Borchers, & Epstein, 
2012), and unsuccessful advocacy (Ferrell, 2006; Gutierrez, 2005).  External sources include 
poor communication patterns and collaboration by healthcare providers, providing false hope 
(Hamric, & Blackhall, 2007; Pavlish, Brown-Saltzman, Jakel, & Fine, 2014) and treatments that 
do not relieve pain or suffering (Ferrell, 2006: Gutierrez, 2005; LeBaron, Beck, Black, & Palat, 
2014) or treatments perceived as medically inappropriate and not in the patient’s best interest, 
following family preferences instead of patient’s wishes due to fear of litigation, and inadequate 
administrative support (Hamric, Borchers, & Epstein, 2012).  Repeated and unresolved 
encounters of moral challenges are theorized to affect the frequency and intensity of moral 
distress, resulting in a cumulative effect or moral residue (Epstein & Hamric, 2009).  Evidence of 
moral challenge includes disagreements about plans of care or disputes with policy, and disputes 
about fair patient and staff treatment (Pavlish et al., 2014).  Pavlish et al. (2014) utilized an 
ethnographic approach to examine ethical conflicts in 30 nurses within the culture and setting of 
oncology.  Nurses described both internal and external sources as elements of poor 
communication, with some providers not speaking up and others not willing to listen or consider 
alternative perspectives (Pavlish et al., 2014).  Moral challenges were perceived as delaying or 
avoiding difficult conversations about poor prognoses or end-of-life care options, followed by 
end-of-life situations that ignored the patient’s autonomy (Pavlish et al., 2014).  As such, the 
researchers concluded that physicians and nurses did not feel supported in discussing their 
differences and missed opportunities to understand each other’s perspectives (Pavlish et al., 
2014).  According to Gutierrez (2005), breaking bad news or discussing poor prognoses can be a 
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catalyst for strengthening moral courage rather than creating missed opportunities between 
patients, families, and healthcare providers.    
Nurse as a Moral Agent and Nurse Characteristics 
The nurse as a moral agent is derived from a fundamental belief that patients have a right 
to self-determination and nurses have a duty to advocate for and to protect the rights of the 
patient (American Nurses Association, 2015).  The American Nurses Association (ANA) Code 
of Ethics provides standards for the nursing practice to guide moral action (ANA, 2015).  As a 
moral agent, the nurse articulates nursing values and maintains the integrity of the profession and 
its practice by striving toward moral action (ANA, 2015).  Nurses assist patients with care 
decisions about resuscitation status, withholding and withdrawing life-sustaining treatments, 
advanced care planning; and facilitating informed decision-making, assisting patients to ask 
questions and ensuring that the information is consistent with their values and preferences (ANA, 
2015, pp. 6-8).  Nurses must also bring forward difficult issues related to patient care and/or 
institutional constraints upon ethical practice for discussion and review (ANA, 2015, p. 16).  
Striving to take moral action requires that individuals address the moral challenge and be morally 
responsible for what they have a moral duty or obligation to do (Lindh, da Silva, Berg, & 
Severinsson, 2010; Sekerka, Bagozzi, & Charnigo 2009).  Moral agents are expected to 
incorporate professional and personal values, drawing upon multiple values in the moral 
decision-making process and effectively sorting out and determining what action should be taken 
while holding firm to previously held values (Sekerka et al., 2009).  Moral agents are also aware 
that their position, identity, and character may be at risk; however, they manage their emotions 
and balance their desire to proceed with the action against other competing threats (Sekerka et 
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al., 2009).  Individuals who proceed with the moral action demonstrate a proactive approach to 
workplace ethics to achieve solutions that serve and benefit the greater good (Sekerka et al., 
2009). 
Moral distress results from not fulfilling one’s moral duties or obligations, or in fulfilling 
them in a morally unacceptable way (Hare, 1981).  Responses from a subset of nurses (n=20), 
extracted and analyzed in a secondary analysis of qualitative data, suggest that nurses’ frustration 
with their inability to provide appropriate pain and symptom relief for a patient may turn into 
personal suffering leading to moral distress (Bernhofer & Sorrell, 2014).  Nurses who knew what 
to do but encountered barriers suffered the most, which may suggest that those with more 
knowledge or education are at greater risk for moral distress if they cannot act on their 
knowledge and skills (Bernhofer & Sorrell, 2014).  In a different study, Browning (2013) 
reported high moral distress intensity as the nurses’ age increased, however, nurses participating 
in end-of-life nursing education (ELNEC) experienced significantly greater levels of moral 
distress intensity and frequency, related to treatments not in the patient’s best interest or external 
sources (Browning, 2013).  This may be explained by nurses having gained more information 
regarding the moral action to take in situations of delivering futile care to dying patients 
(Browning, 2013).  There are conflicting findings with respect to key nurse demographic 
variables, and lacking from these studies are information pertaining to how nurses assimilate 
ethics education and translate it into practice.  A majority of studies suggest that referrals to the 
ethics committees or establishing ethics rounds and moral communities may promote comfort 
with ethics-related conversations and ease moral distress (Pavlish, Brown-Saltzman, Jakel, & 
Fine, 2014; Rice, Rady, Hamrick, Verheijde, & Pendergast, 2008; Zuzelo, 2007).  However, 
findings from one study revealed that 75% (n=75) of the nurses had never initiated an ethics 
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consultation related to a patient care dilemma, only 30% had completed a college level course in 
biomedical ethics, 70% had not completed any undergraduate ethics courses and 85% had not 
undertaken continuing education in ethics (Zuzelo, 2007).  Some nurses had not received any 
formal education in the area of ethics (Gutierrez, 2005).  Assessing baseline information on how 
ethics education is acquired and assimilated is essential to understand how this type of education 
is translated in practice and utilized to improve ethical work environments.  
Previous studies have found that years of experience in nursing were positively correlated 
with Moral Distress scores (Elpern, Covert, & Kleinpell, 2005).  However, another study 
concluded that younger nurses (age 18 to 30 years old) scored significantly higher than the older 
nurses; those with bachelor’s degree or higher had significantly higher distress scores compared 
with associate’s degree nurses (Meltzer & Huckabay, 2004).  Predictors of moral distress 
intensity were greater after 34 years of age, after 3 years at current employment, and after 6 years 
of nursing experience (Rice et al., 2008).  In contrast, Mobley and colleagues (2007) found that 
there were no significant associations between the moral distress intensity and age, critical care 
experience, and total years in nursing practice.  However, moral distress frequency related to 
futile care (external sources) was significantly associated with nurses who were over 33 years of 
age, had critical care experience greater than 4 years, and had a total of years in nursing practice 
greater than 7 years (Mobley et al., 2007).  In Sirilla’s (2014) study, there was a statistically 
significant inverse relationship between education and Moral Distress scores.  Nurses with 
higher education had lower moral distress scores (Sirilla, 2014).  Additionally, the only predictor 
of Moral Distress scores was the type of nursing unit when age, education, years of nursing 
experience, years of experience in oncology, and years with the current employer were included 
in the model (Sirilla, 2014).  At this time, findings on moral distress and oncology nurse 
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characteristics are inconclusive.  Consequently, further studies are needed to determine moral 
distress in oncology nurses and the specific characteristics associated with moral residue and 
moral courage.   
Moral Distress and Moral Distress Residue 
Moral distress residue is described as the cumulative effect that can remain long after a 
morally distressing situation occurs whereby the nurse’s core values become compromised 
(Webster & Bayliss, 2000).  The frequency and intensity of a morally distressing situation is 
associated with moral residue.  The repeated encounters and unresolved distress have a 
cumulative effect (Hamric, 2012).  This phenomenon has been linked to emotional exhaustion, a 
measure of burnout (Meltzer & Huckabay, 2004).  Emotionally exhausted nurses can lose their 
ability to be compassionate, leading to their resignation from their position (Corley et al., 2001; 
Hamric & Blackhall, 2007) or leaving the profession entirely (Corley, 2002).  Evidence suggests 
that nurses with the highest levels (both frequency and intensity) of moral distress were likely to 
have left a previous nursing job or considered leaving their jobs (Cavaliere, Daly, Dowling, & 
Montgomery 2010; Corley, Elswick, Gorman, & Clor, 2001; Ferrell, 2006; Gutierrez, 2005; 
Lazzarin, Biondi, & DiMauro, 2012; Maningo-Salinas, 2010; Sirilla, 2014).  
Corley, Elswick, Gorman and Clor’s (2001) seminal research is most widely cited in 
studies.  Corley et al. (2001) developed and evaluated the original Moral Distress Scale (MDS) 
to examine the effect of moral distress on previous decisions about resigning a nursing position.  
Nearly 74% (n=158) of the nurses responded to the item about having left a previous job because 
of moral distress, of which 15% (n=23) had actually left a previous job because of moral distress.  
Nurses who had resigned from a previous job or who were contemplating leaving their jobs were 
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associated with higher Moral Distress scores (Corley et al., 2001).  In another study examining 
moral distress in five separate healthcare provider groups, moral distress was statistically 
significantly higher for healthcare professionals who had previously considered and actually left 
a position compared with those who had not considered leaving (Allen, Judkins-Cohn, deVelasco 
& Forges, 2013).  Moral distress was also statistically significant for healthcare professionals 
who were currently considering leaving a position compared with those who were not (Allen et 
al., 2013).  One large Italian study evaluating moral distress in pediatric oncology nurses (n=182) 
reported that Moral Distress frequency scores were highest among respondents related to 
following orders for pain medication even when the medication prescribed did not control the 
pain, and providing care that did not relieve the child’s suffering because the physician feared 
increasing the dose of pain medication would cause death (Lazzarin, Biondi, & DiMauro, 2012).  
Of these respondents, 50.5% indicated that they had considered changing their jobs or work unit 
and 13.7% had actually changed their unit or hospital due to moral distress (Lazzarin, Biondi, & 
DiMauro, 2012).  Although working with children with cancer is psychologically difficult, these 
pediatric oncology nurses identified external sources (time constraints, medical power, policy, 
and administration) as the main component or source of their moral challenge (Lazzarin, Biondi, 
& DiMauro, 2012).   
According to Epstein and Hamric (2009) morally distressed individuals behave morally 
ineffective in part because their views have not been addressed, and their core values have been 
compromised.  Although not directly measured, Pavlish et al. (2014) deduced that during moral 
conflict, the nurses’ emotions intensified and some conflicts were unresolvable.  This reasoning 
may support Epstein and Hamric’s (2009) claim that providers react more strongly to repeated 
situations which, if unresolved, could erode moral thinking and manifest as moral residue.  As 
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moral distress and residue accumulate, providers could become emotionally exhausted (Hamric, 
2012; Meltzer, & Huckabay, 2004).  Moral distress residue has been difficult to quantify; 
presumably it is a latent variable (Epstein & Hamric, 2009), and studies have not consistently 
reported outcomes pertaining to this variable. 
Moral Courage 
Courage is described as an inner strength or quality that is fundamental to taking moral 
action (Hawkins & Morse, 2014).  Nurses who take a stand and act accordingly, regardless of the 
perceived or actual threat when moral principles are threatened demonstrate moral courage 
(Lachman, Murray, Iseminger, & Ganske, 2012).  In general, moral courage is preceded by 
challenges or threats (Hawkins & Morse, 2014).  A threat to the patient may include pain and 
suffering while challenges to the physician or nurse include delivering bad news to a patient or 
family with a poor prognosis or confronting unethical practice (Hawkins & Morse, 2014).  Moral 
courage is also manifested in examples of patient advocacy in the face of fear and retribution 
(Lachman, 2007a).  Outcomes of courage include acting in the patient’s best interest by 
alleviating pain or suffering, communicating with patients and family openly, and collaborating 
with physicians effectively (Hawkins & Morse, 2014).  The moral agent manages negative 
emotions that may accompany the challenging situation, even risking personal character and 
position (Sekerka, Bagozzi, & Charnigo, 2009).  However, knowledge is lacking about nurses’ 
courageous actions in their practice.  Although there are vast empirical studies on nurses’ moral 
distress in practice, studies on moral courage in nursing have been limited in the literature.  
The science regarding moral courage in nurses is mostly anecdotal, conveying the 
experiences of others (Lachman, Murray, Iseminger, & Ganske 2012).  But a handful of 
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qualitative studies, mainly phenomenography or hermeneutic approaches on courage in nursing 
appear in the literature (Gustafsson, Asp, & Fagerberg, 2009; Spence, 2004; Spence & Smythe, 
2007).  As such, courage was described as the capacity to overcome fear, stand up for one’s core 
values and the willingness to speak out or take action in an assertive and principled manner 
(Spence, 2004).  Spence and Smythe (2007) explored moral courage in nurses (n=20) and 
revealed that it was expressed in response to threats or challenges.  The nurses reported that they 
became cautious and sought support which afforded them the opportunity to uphold their 
professional nursing standards and safeguard patients’ rights and safety (Spence & Smythe, 
2007).  Additionally, nurses (n=7) portrayed moral courage by questioning their own and others’ 
behavior and actions (Gustafsson et al., 2009) and as a result nurses with courage experienced 
personal and professional growth (Ferrell, 2006).  It has been suggested that features of nursing 
action and moral courage include willingness to recognize and be sensitive to the suffering of 
others, expression of empathy and compassion, helping those in need, doing something to 
alleviate the suffering of others, and challenging the status quo (Lindh, da Silva, Berg, & 
Severinsson, 2010).  
Incidental findings of courage have been detected in moral distress literature. A common 
barrier to taking moral action and resolving a moral conflict identified by 67% (n=8) of the 
nurses was disagreement about patient care goals among the physician, the patient’s family and 
the nurse (Gutierrez, 2005).  These nurses were aware of their moral obligation but were 
inhibited from discussing their moral differences.  In this instance, the nurses may have lacked 
the skills or moral courage to negotiate the moral conflict.  Spence and Smythe (2007) described 
moral courage relative to creating opportunities in a space between chance and security.  Moral 
distress was likely a struggle against limitations between chance and security that hindered good 
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care.  Little is known about what influences a nurse to respond to morally distressing situations 
with moral courage.  In one study by Ferrell (2006), participants were instructed to reflect on a 
medically futile clinical experience or their experience with an ethical issue at end of life and to 
describe how the experience personally affected them.  An interesting response shared by 29% 
(n=32) of the nurse participants was that they had become stronger advocates for respecting their 
patients’ preferences (Ferrell, 2006).  Courage is exhibited in advocacy when the nurse takes a 
stand on behalf of the patient regardless of the consequence (Hawkins & Morse, 2014).  
Researchers Wiegand and Funk (2012) used a descriptive approach to studying clinical 
situations generating moral distress in critical care nurses.  Data were collected using an open-
ended survey to ascertain situations that caused moral distress in nurses and what the nurses 
would do differently.  The nurses also proposed future actions (Wiegand & Funk, 2012), but 
whether or not those interventions have been effective and how nurses intervene in future action 
after experiencing moral distress remains ambiguous.  It is unclear whether nurses who do not 
intervene have higher moral distress than those who do intervene.  It is also unknown if those 
who do intervene manifest moral courage and incorporate strategies to be more assertive on 
moral issues.   
Opportunities exist to develop interventions related to moral courage in nursing.  To date, 
quantitative studies on moral courage have been conducted in the business sector (Priesemuth, 
2013) and military setting (Sekerka, Bagozzi & Charnigo, 2009).  For example, Sekerka et al. 
(2009) conducted a longitudinal study to develop ethics education, and create and test a scale to 
measure professional moral courage in U.S. Naval officers.  Critical incident interviews and 
coding resulted in five themes and statements, which were tested in a different sample of officers 
(Sekerka et al., 2009).  The themes are moral agency, multiple values, endurance of threats, 
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going beyond compliance, and moral goals.  Findings from the study demonstrate that 
individuals were predisposed toward moral behavior or taking moral action because they viewed 
themselves as moral agents, and automatically took ownership of the challenge (Sekerka et al., 
2009).  
The current study adds to the literature by investigating the relationship between moral 
distress, moral distress residue and moral courage.  Furthermore, understanding these 
relationships is a key aspect to designing interventions and targeting resources where they are 
needed most to alleviate moral distress and strengthen moral courage among nurses. 
Gaps in Literature 
Throughout the literature, there is evidence that moral distress is a serious concern 
associated with certain clinical situations and some nurses experience moral distress residue and 
leave their jobs.  There have been intangible and incidental findings of moral courage in the 
literature on moral distress.  Opportunities exist to develop the empirical knowledge base of 
moral courage and to explore nurses’ experiences with moral courage; for example, identifying 
what characteristics promote or inhibit moral courage as well as which actions or activities 
exemplify moral courage will expand the knowledge base (Lachman, Murray, Iseminger, & 
Ganske, 2012).  Accordingly, the current study expands research by providing a framework to 
explore the relationship between moral distress, moral distress residue, and moral courage.  
Furthermore, the current study examines the relationships between moral distress, moral distress 
residue, and moral courage in oncology nurses in both the inpatient and outpatient settings.  
Determining which nurse characteristics are predictors of moral distress and moral courage can 




 As changes in health care become more complex, oncology nurses are at risk for moral 
distress as they carry out routine care for patients with serious and terminal cancers.  Studies on 
moral distress have focused on nurses’ weakness and suffering rather than exemplifying their 
strengths.  One positive solution is to recognize that moral distress can be a catalyst for 
strengthening moral courage, opening dialogue and self-reflection, and not just be a source of 
suffering (Peter & Liaschenko, 2013).  Little is known about the relationship between moral 
distress, moral distress residue, and moral courage in oncology nurses.  This study uses Hamric’s 
revised 21-item Moral Distress in Healthcare Professionals Measurement Scale (MDS-R), and 
Sekerka et al.’s 15-item Professional Moral Courage Scale to evaluate the relationships between 
oncology nurse characteristics, moral distress, moral residue and moral courage.  Furthermore, a 
qualitative open-ended question regarding how courage is exemplified contributed to a 
comprehensive understanding of the results.  Moral courage is needed for moral action so that 




CHAPTER THREE: METHODOLOGY 
 
The purpose of this study was twofold: (1) examine the relationship between moral 
distress, moral residue, and moral courage in oncology nurses working in the adult inpatient and 
outpatient settings, and (2) identify which oncology nurse characteristics are predictors of moral 
distress and moral courage and specifically, what oncology nurse actions illustrate moral 
courage.  The study employed a mixed method, non-experimental, correlational design and 
qualitative content analysis to illuminate the quantitative data.  The chapter discusses the 
research methodology, study design, description of the population, data collection, sampling, 
instrumentation, and procedures.  
Research Questions 
The research questions guiding this study were as follows: 
1) Is there a difference between oncology nurses in adult inpatient and outpatient settings 
with respect to their moral distress and moral courage?  
2) Among oncology nurses, to what extent, if any, are moral distress and moral courage 
related?  
3) What is the level of moral distress as reported by oncology nurses who report moral 
distress residue described as having left a previous job, considered leaving a previous job 
but stayed, or considering leaving a current job now?  
4) Which of the following nurse characteristics (education level, total number of years 
working as registered nurse, total number of years working as oncology nurse, oncology 
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setting, oncology certification, ELNEC education, ethics education, and participation in 
ethics consult) are significant predictors of Moral Distress in oncology nurses? 
5) Which of the following nurse characteristic (education level, total number of years 
working as registered nurse, total number of years working as oncology nurse, oncology 
setting, oncology certification, ELNEC education, ethics education, and participation in 
ethics consults) are significant predictors of Professional Moral Courage in oncology 
nurses? 
6) What actions are indicative of moral courage?  Specifically, if you experienced a morally 
challenging situation, describe how you took a stand for your patient; what influenced or 
inhibited your action?  What was the outcome of your stand?  How did that make you 
feel?  
Design 
A mixed methods cross-sectional correlation design and qualitative content analysis was 
used to investigate oncology nurses’ characteristics and the relationships between moral residue, 
and scores on the Moral Distress and Moral Courage Scales.  A parallel approach using one 
open-ended qualitative statement, collected at the same time with the demographic and 
quantitative data, was implemented to yield deeper explanations of findings from the quantitative 
analysis (Creswell, Fetters, & Ivankova, 2004).  In parallel combinations the methods are used 
separately and the findings are integrated after the data are analyzed.  This survey methodology 
is practical and acceptable to participants because it is anonymous, and there is no manipulation 
of intervention and no randomization of subjects is required (Polit & Beck, 2012).  Internal 
threats to validity such as selection bias and external threats related to whether relationships 
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observed hold true over variations in people and settings are limitations and there is no 
possibility of exploring cause and effect (Polit & Beck, 2012).  
Setting and Sample 
Prior to conducting the study, approval from the University of Central Florida 
Institutional Review Board (Appendix A) and the Oncology Nurses Society (Appendix B) were 
obtained.  A convenience sample of 274 nurses was drawn from a population of 2,423 oncology 
nurses recruited from the membership roster of the Oncology Nursing Society (ONS) in the 
Southeastern United States.  ONS is a national association that has over 35,000 registered nurses 
and other healthcare professionals (ONS, 2013).  Oncology nurses who are members of ONS, 
English reading, with work experience in the adult oncology inpatient or outpatient settings and 
with one or more years of work experience, currently working full-time, or retired within six 
months or less at time of the survey met the inclusion criteria.  Licensed practical nurses (LPNs), 
or nurses working part time, per diem, or in pediatrics were excluded from the study.  A different 
instrument is necessary for the pediatric oncology nurses; because of time and cost, it was not 
feasible to include pediatric oncology nurses in the study.  A power analysis determined a 
minimum sample size of 159 was required to detect statistical significance.  A response rate of 
15-20% was expected based on similar studies (Beckstrand, Collette, Callister, & Luthy, 2012; 
Radzvin, 2011).  The sample was assumed to be representative of the population of oncology 
nurses who are members of the professional organization. 
Sampling 
The software program G-Power 3.1.7 was used to calculate the minimum required sample 
size, per statistical analysis (Faul, Erdfelder, Lang, & Buchner, 2007).  Power analysis was 
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conducted for the research questions except question six.  Research question six is an open-
ended question intended to gather qualitative data for the study.  When estimates from pilot data 
or prior research is not available, a last resort is to use a small, medium or large conventions 
(Polit, 2010), thus a medium effect size was feasible as an estimate in order to calculate the 
number of subjects needed to avoid a Type II error (Polit, 2010; Sullivan & Feinn, 2012).  
Cohen’s (1988) effect size guidelines were used to determine the effect sizes for the following 
research questions.  According to Cohen (1988), an effect size of .20 in a two-group mean 
difference test is considered small, .50 is medium, and .80 is large.  Research question one was 
addressed with an independent-samples t test to compare differences in respondents’ mean scores 
for Moral Distress working in inpatient and outpatient settings.  Using a medium effect size d 
=.50 a power of .80 and an alpha level of .05 for a two-tailed test, the calculated total sample size 
of 128 (or 64 in each group) was required.   
Research question two was addressed with a Pearson Correlation.  As such, the sample’s 
coefficient r is used to estimate the effect size.  A correlation coefficient of .10 represents a weak 
or small association; a correlation coefficient of .30 represents a moderate correlation; and a 
correlation coefficient of .50 or larger represents a strong or large correlation (Polit, 2010, p. 
202).  Respondents’ scores for Moral Distress and Moral Courage were correlated to determine 
what type of relationship, if any, occurred between the scores.  Using a medium effect size = .30, 
power of .80, and an alpha level of .05 for a two-tailed test, the calculated minimum sample size 
of 85 participants was required for question two.   
Research question three was addressed with ANOVA to compare the Moral Distress 
mean scores of three groups.  Cohen’s (1988) conventional values for small, medium, and large 
effects correspond to values of eta-squared (η
2
) of .01, .06, and .14 respectively (Polit, 2010, p. 
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159).  Using an effect size η
2
 = .06 and alpha = .05, 53 participants per group was needed to 
achieve a power of .80; or total sample size of 159 participants.   
Research questions four and five were addressed with multiple regressions.  A power 
analysis is a precise way to determine sample size for multiple regression (Polit, 2010).  Cohen’s 
(1988) guidelines for effect size, referred to as f
2





= .02, moderate when R
2
 = .13, and large when R
2 
= .30 (Polit, 2010, p. 242).  
Given a moderate or medium effect size (f
2
 = .13), power of .80, eight predictors (at least eight 
independent variables), and an alpha level of .05 for a two tailed test, the calculated minimum 
sample size requirement of 109 participants was required for questions four and five.  The power 
analysis for research questions four and five assumed that each predictor was statistically 
significantly related to the dependent variable, and thus, the regression model proposed, at most, 
eight predictors.  The researcher used the sample size requirement for the most stringent analysis 
to set the minimum sample size for this study.  In the event of missing data, oversampling was 
done and all collected surveys were analyzed resulting in 187 subjects in the study. 
Instrumentation 
Moral Distress Scale-Revised (MDS-R) 
The Moral Distress in Healthcare Professionals Measurement Scale (MDS-R) is a 21-
item, 0-4 point scale with two closed-ended variables.  The scale measures an individual’s 
perception to a situation based on two dimensions (frequency of the encountered situation and 
the intensity of distress) and moral residue described as having left a previous job when moral 
distress was not resolved (Appendix C).  The scale represents the dependent variable and 
measures both continuous and dichotomous data.  All 21 items were scored by participants in 
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terms of how often the situations arose, or frequency, and the level of disturbance on the scale, or 
intensity (Hamric, Borchers, & Epstein, 2012).  The scale for frequency ranges from 0 = never to 
4 = very frequently, while intensity ranges from 0 = none to 4 = great.  Composite scores were 
calculated using SPSS.  The scores for the 21 items have a range of 0 to 336 for a total score. 
The scale contains a definition of moral distress and instructions for completing it.  Respondents 
could also write up to two statements specific to their practice environment in which they had 
experienced moral distress and indicate the level of frequency and intensity.  However, these 
items are not calculated in the total score.  Instead, descriptive statistics were used to discuss the 
findings.  
Content validity was evaluated by four experts familiar with the research on moral 
distress by independent review of the 21 items, coding of primary and secondary sources of 
moral distress in the revised items, and evaluating clarity and concision of the items for a 
multidisciplinary provider (Hamric, Borchers & Epstein, 2012).  This tool demonstrated good 
internal consistency (Cronbach α = 0.89) and an 88% inter-rater agreement on both primary and 
secondary sources of moral distress situations (Hamric et al, 2012).  Full agreement was reached 
for 19 of 21 items, resulting in one item being replaced and another item reworded substantially 
(Hamric et al, 2012). 
Hamric et al (2012) evaluated construct validity by testing hypothesis regarding the 
relationships between moral distress and other variables identified in previous research.  Each of 
the three hypotheses was supported for the nurse population.  Nurses with more experience in 
their current positions demonstrated higher moral distress (r = .22, p = .005); moral distress was 
negatively correlated with ethical climate (r= -.402, p < .001) and MDS-R scores were 
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significantly higher for those considering leaving their positions now (p < .001) (Hamric, 
Borchers & Epstein, 2012).   
Moral Distress Residue 
The final section of the MDS-R scale contained two questions developed by the 
researchers of the instrument (Hamric, Borchers, & Epstein, 2012).  The first question evaluates 
moral distress residue as described by respondents who had left a previous job or considered 
quitting a previous job. The second question evaluates current levels of moral distress as 
described by respondents considering quitting a current job now due to moral distress (Hamric, 
Borchers, & Epstein, 2012).  The two questions were:  
1. Have you ever left or considered quitting a clinical position because of your moral 
distress with the way patient care was managed at your institution?  
a. No, I’ve never considered quitting or left a position. 
b. Yes, I considered quitting but did not leave. 
c. Yes, I left a position. 
2. Are you considering leaving your position now? Yes, No. 
Responses to these questions captured the latent or proxy variable for moral residue 
within the study.  The developer found that higher moral distress scores were reported in nurses 
who had left a previous position, followed by those who considered leaving a previous position 
but stayed; nurses who never left or considered quitting had lower moral distress scores (Hamric, 
Borchers, & Epstein, 2012).  
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Professional Moral Courage Scale 
Sekerka, Bagozzi and Charnigo (2009) Professional Moral Courage Scale (PMCS) is a 
15-item, 7-point unipolar scale (Appendix D) that measures a respondent’s response from 1 = 
never true to 7 = always true, with 4 = sometimes true as a midpoint.  The PMCS has five themes 
or dimensions which include 1) moral agency, 2) multiple values, 3) threat endurance, 4) beyond 
compliance, and 5) moral goal.  Moral agency pertains to qualities or characteristics of the moral 
agent.  Multiple values pertain to the application of personal and professional codes of conduct in 
making decisions.  Threat endurance pertains to taking the moral action in the face of challenges 
or social pressures.  Beyond compliance relates to striving to achieve the moral standard.  Moral 
goal is actualization or attainment of the moral standard.  Each dimension contains three items.  
The items measuring moral courage were obtained by two different researchers and derived from 
analysis of the literature and qualitative analysis of critical incidents (Sekerka, Bagozzi, & 
Charnigo, 2009).  
Construct validity was examined by confirmatory factor analysis (CFA) (Sekerka, 
Bagozzi, & Charnigo, 2009).  The factor loadings were all high in value and statistically 
significant.  The true-score or trait variances for the five moral courage dimensions were 
substantial except for one measure, the measure beyond compliance (Sekerka, Bagozzi, & 
Charnigo, 2009).  The trait variances ranged from 52% to 77%.  The minimum standard is 
acknowledged to be 50%; the measure of beyond compliance achieved a trait variance of 37% 
(Sekerka, Bagozzi & Charnigo, 2009).  The authors did not report a Cronbach alpha. 
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Moral Courage Examined Qualitatively 
 The open-ended question ascertained how the nurse demonstrated moral courage 
(specifically, if they experienced a morally challenging situation, how they took a stand for their 
patient and what was the outcome of their stand?  How did that make them feel?).  
Demographic Data and Survey 
The demographic data and survey contained 13 demographic variables and one additional 
variable addressed through an open-ended question represented the independent variables 
(Appendix E).  The demographic data and pertinent open-ended question were derived from the 
literature review and believed to be relevant to this study.  The demographic data were 
comprised of continuous and categorical data (age, gender, education level, total number of years 
working as nurse, total number of years working as oncology nurse, work setting 
(inpatient/outpatient, other), oncology certification, ELNEC education, ethics course 
work/continuing education, participation in ethics consultation).  
Procedures 
Recruitment 
The Principal Investigator (PI) sent a written proposal to ONS to obtain permission to 
recruit member oncology nurses residing in two states within the Southeastern United States.  
Prior to conducting the study, approval was obtained from the University of Central Florida 
Institutional Review Board and the Oncology Nursing Society (ONS).  The PI did not have direct 
access to the membership email.  The study was disseminated on February 27, 2015 by ONS 
through email to 2,400 oncology nurse members in the targeted study population.  An 
abbreviated email (Appendix F) served as a cover letter announced the study and invited 
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prospective participants to join the study.  The abbreviated email described the study purpose, 
value of the investigation, instructions for completing the survey, risks, benefits, and process to 
ensure confidentiality, and who to contact for questions or assistance.  Interested prospective 
participants accessed the study using the embedded link to the Qualtrics ™ online survey.  
Completion of the survey was deemed an informed consent.  The total study time required was 
15-20 minutes.   
Data Collection  
Qualtrics™, the online survey software, was used to generate the electronic demographic 
data and survey, MDS-R which measures Moral Distress and Moral Residue, the Professional 
Moral Courage Scale, and the open-ended question on Moral Courage for the data collection.  
First, explanation of the study (describing the study purpose, what the participants would be 
asked to do in the study, time required, risks/benefits, anonymity, and how to contact to principal 
investigator) was provided to the participants.  Next, participants completed the Demographic 
Data Sheet which also contained 13 brief response items and one open-ended question on Moral 
Courage, followed by the 21-item Moral Distress Scale-Revised (MDS-R), containing also the 
Moral Residue items, and the 15-item Professional Moral Courage Scale.  Enrollment lasted for 
one month with one email reminder generated after week two.  Data collection ended on March 
31, 2015. 
Confidentiality 
The online survey was anonymous and no personal identifying information such as name 
or special coding was used in the study data.  Participation in the study was voluntary and 
participants were given directions to contact the PI if they had any questions during the survey or 
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after the survey was completed.  There were no known risks, penalties or costs for participation 
in the study.  The returned surveys were kept in a password-protected computer.  Only the PI and 
research advisors had access to the online survey and study data.  The study data will also be 
shared with the developer of the MDS-R. The study results will be reported in the aggregate and 
will be published. 
Operationalizing Variables 
Moral Distress Scale-Revised (MDS-R) 
The Moral Distress Scale represents the dependent and independent variables, and items 
on the scale contain continuous data.  
Moral Distress Residue 
Moral distress residue is a measure of nominal data and was coded, no = 0, and yes = 1. 
Individuals reporting having left a position or considered leaving a position but stayed were 
coded ‘1,’ reflecting the fact that they have experienced moral residue.  Respondents reporting 
never left were coded ‘0.’ Respondents who are currently considering leaving their positions 
were coded ‘1’ to reflect current levels of moral distress.  Respondents not leaving a current 
position were coded ‘0’ 
Professional Moral Courage Scale and open-ended question 
The moral courage scale represents the dependent variables, and items on the scale are 
continuous data.  The open-ended question was coded into themes using a preliminary set of 
codes and the five sub themes from the Professional Moral Courage Scale.  
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Demographic Data and Survey Questions 
The demographic data and survey questions represent the independent variables.  These 
variables contain both continuous and categorical data.  For example, age is continuous, level of 
education was coded as 0 = BSN or lower and 1 = MSN or higher.  To examine the categorical 
data, dummy coding was used for dichotomous variables with two categories and effects coding 





CHAPTER FOUR: RESULTS 
 
Analysis of Data 
The purpose of this study was to determine the relationship between moral distress, moral 
residue, and moral courage; whether oncology nurse characteristics were predictors of moral 
distress and moral courage; and specifically what actions were indicative of moral courage.  A 
convenience sample of oncology nurses, working in oncology adult inpatient and outpatient 
settings were recruited for this study.  The participants who were English-speaking, registered 
nurses, working full time, or retired within six months or less met the inclusion criteria.  A mixed 
method, non-experimental, correlation design was used to answer the research questions.  Data 
were analyzed using the Statistical Package for the Social Science (SPSS) version 22.0 software 
for Windows.  Descriptive and inferential statistical analysis and findings of the qualitative 
content analysis that describe the participants’ moral courage are presented in this chapter.  First, 
the preliminary data examination and descriptive statistics conducted on the data collected in this 
study are presented.  Next, results of the statistical analyses related to the research questions one 
to five are presented.  Last, the qualitative content analysis is presented for question six.  Finally, 
the links between qualitative and quantitative findings are explored.  
Description of Sample 
Quantitative data were entered into SPSS version 22 for Windows to perform data 
examination and analysis.  Of the 2,400 eligible oncology nurse participants, the raw data set 
consisted of 274 respondents representing a response rate of 11.4%.  A total of 76 (27.7) 
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respondents had missing data of which 9.2% (n=7) accessed the study and dropped out without 
completing the demographic information and study survey.  Of the 76 respondents, 91% (n=69) 
completed the demographic information, but did not complete the moral distress or professional 
moral courage scales. Therefore, 76 cases were removed from the study leaving 198 for analyses.  
The remainder of missing data for the MDS-R and PMCS scales were imputed wherever 
possible.  Specifically, for the MDS-R, missing frequency and intensity scores were imputed 
using the sample mean (Mertler & Vannatta, 2010).  Intensity scores could not be imputed for 
seven respondents who did not provide any intensity scores, these respondents were removed 
from the analysis leaving 191 subjects.  For the PMCS, missing scores were imputed using the 
sample mean.  One respondent did not provide any PMCS scores, so this respondent was 
removed from the study retaining 190 participants for analysis.  The presence of outliers was 
assessed using box plots.  Outliers are values below Q1-1.5(Q3-Q1) or above Q3+1.5(Q3-Q1) or 
equivalently, values below Q1-1.5 IQR or above Q3+1.5 IQR (Mertler & Vannatta, 2010).  The 
interquartile range was defined as the difference between the third quartile (Q3) and the first 
quartile (Q1) (Mertler & Vannatta, 2010).  The box plot in Figure 2 showed two outliers for the 
MDS-R (high value of 224 and 264).  These respondents did not provide a response to the open-
ended question.  The outliers were inspected and removed one at a time and Figures 3 shows box 
plot after extreme outliers were removed for MDS-R.  One outlier for the PMCS (low value of 
3.93) was identified and removed (see Figures 4 and 5).  After the removal of dropouts, missing 






Figure 2. MDS-R with outlier 
 





Figure 4. PMCS with outlier 
 
Figure 5. PMCS after outlier removed  
 The demographics for this sample are presented in Table 1.  The participants had a mean 
age of 52 years (SD = 10.3).  The mean number of years of experience working as a nurse was 
reported as 24 (SD = 11.7, Range = 3 - 50 years).  The mean number of years working as an 
oncology nurse was 17 (SD = 9.9, Range = 1 - 45 years), of which 59 (32%) had 1-10 years of 
oncology work experience; 67 (36%) had 1-20 years of oncology work experience; 39 (21%) had 
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21-30 years of oncology work experience; 18 (10%) had 31-40 years of oncology work 
experience; and 2 (1%) had 41-45 years of oncology work experience. Thirty six percent of the 
respondents (n=68) worked with inpatients, 61% (n=114) worked with outpatients, and 3% (n=5) 
worked in ‘Other’ work setting, such as academic, research, and home health.  Eighty-two 
percent (n=154) of the respondents had specialty certification in oncology and 41% (n=77) had 
attended an end of life and palliative care education provided by the End of Life Nursing 
Education Consortium (ELNEC).  
Descriptive Statistics of Demographic Variables 
Table 1 
Demographic Characteristics of the Sample N= 187 
Variables                                 N (%) 
  
Age                                 (M = 52, SD = 10.3)  
   Range   
       25-30               8(4.0) 
       31-40                20 (11) 
       41-50-               52 (20) 
       51-60 73 (39) 
       61-70 33 (18) 
       71-80 1(1.0) 
Gender  
Female 180 (96) 
Male 7(4.0) 
Race/Ethnicity  
White/Caucasian 132 (76) 





Full time (36+ hours per week) 157 (84) 
Part Time 12(6.0) 
Per Diem 8(4.0) 
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Variables                                 N (%) 
Retired, 3 months or less 6(3.0) 
Education (highest degree)  
Diploma 8(4.0) 
Associate’s Degree  43(23) 
Bachelor’s Degree 78(42) 
Master’s Degree 45(24) 
DNP 3(2.0) 
PhD/DNSc 9(5.0) 
Current Work Setting  
Inpatient Unit 68(36) 
Outpatient Clinic 114(61) 
Other 5 (3) 
Oncology Nurse Certification  
Yes 154(82) 
   No 33(18) 
ELNEC Course  
Yes 77(41) 
No 110(59) 
Basic Health Care Ethics  
Ethics content integrated into program 130(70) 
Separate ethics course 39(21) 
No ethics content 18(10) 
Additional Courses or Ethics CEU  
Yes 112(80) 
No 74(40) 
Participated in Ethics Consult  
Yes 49(26) 
No 136(74) 
Moral Residue  
Intent to quit current job now 
 position  
31(17) 
Left or considered leaving previous job /no intent to quit current job 80(44) 
Never considered quitting or left previous job/no intent to quit now 73(39) 
 
Reliability Analysis 
Internal consistency for each of the composite variables and subscales was assessed with 
Cronbach’s alpha reliability analysis.  In this study, MDS-R reliability was supported with a 
Cronbach α of .90.  This finding was consistent with previous results (Allen et al, 2013; Hamric, 
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Borchers, & Epstein, 2012; Whitehead et al, 2015).  In this study, PMCS had a Cronbach α of 
.93.  Results of the reliability testing are presented in Table 2.  Reliability values for all subscales 
were acceptable. 
Table 2 
Cronbach’s Alpha Reliability Testing Results for Moral Distress Scale-Revised and Professional 
Moral Courage Scale and Subscales 
Scale α No. of items Items 
Moral Distress Scale-Revised (MDS-R) .90 21 1-21 
Professional Moral Courage Scale (PMCS) .93 15 1-15 
PMCS subscales    
    Moral Agency .84 3 1, 2, 3 
    Multiple Values .80 3 4, 5, 6 
    Endures Threat .84 3 7, 8, 9 
    Goes Beyond Compliance  .79 3 10, 11, 12 
    Moral Goal .81 3 13, 14, 15 
 
Descriptive Statistics of Instrument (MDS-R and PMCS Scores) 
Moral Distress Scale 
Moral Distress Scale-Revised (MDS-R Score) is defined as the sum of the individual 
frequency x intensity of all 21 responses in the MDS-R instrument.  After imputation using the 
sample mean, the MDS-R Score was summarized in Table 3.  This score ranged from 13 to 201 
points (higher scores indicate greater moral distress), with mean = 81.5 and standard deviation 
=37.2.  The skewness of MDS-R Score was 0.67 (Std Error = 0.18) indicating that the score was 
skewed to the right. The kurtosis of MDS-R Score was 0.69 (Std Error = 0.35).  The histogram is 




Descriptive Statistics Moral Distress Scale-Revised (MDS-R) 
 N Range Minimum Maximum Mean Std. Dev Skewness Kurtosis 









188.0 13.00 201.00 81.5036 37.24784 .670 .178 .690 .354 
 
 
Figure 6. Histogram of the MDS-R Score further illustrates the skewness of the score 
distribution. 
The moral distress frequency x intensity (fxi) scores for each of the 21 items was also 
calculated to obtain the fxi mean score for each item with a mean score ranging from low 1.20 
(SD= 2.52) to high 6.10 (SD=4.72).  For example items less distressing had low fxi mean scores, 
such as: #15 Take no action about an observed ethical issue because the involved staff member 
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or someone in a position of authority requested that I do nothing (M=1.20, SD=2.57); and #14 
Increase the dose of sedatives/opiates for an unconscious patient that I believe could hasten the 
patient’s death (M=1.31, SD=2.498).  The most morally distressing event associated with the 
highest mean score in this study was #2, Witness healthcare providers giving false hope to a 
patient or family.  The top three (by rank order) most morally distressing events differed by work 
setting.  For example nurses in the inpatient setting reported #3 Following the family’s wishes to 
continue life support even though I believe it is not in the best interest of the patient, #2 witness 
healthcare providers giving false hop to a patient or family, and #4 initiate extensive lifesaving 
actions when I think they only prolong death.  Nurses in the outpatient setting reported #2 
Witness healthcare providers giving false hope to a patient or family, #18 witness diminished 
patient care due to poor team communication, and #17 work with nurses or other healthcare 
providers who are not as competent as patient care requires. Table 4 represents the total sample 
21-item Moral Distress fxi mean scores and standard deviations in rank order. 
Table 4 
21-item Moral Distress Scale-R Frequency times Intensity Scores (fxi) Mean Scores and 
Standard Deviations in Rank Order.  
Moral Distress Item (fxi) Mean SD Rank 








3.  Follow the family’s wishes to continue life support even though 
I believe it is not in the best interest of the patient. 
5.62 4.61 
3 










Moral Distress Item (fxi) Mean SD Rank 




17.  Work with nurses or other healthcare providers who are not as 
competent as the patient care requires. 
5.34 4.56 
7 
6.  Carry out the physician’s orders for what I consider to be 
unnecessary tests and treatments. 
5.10 4.28 
8 
1.  Provide less than optimal care due to pressures from 
administrators or insurers to reduce costs. 
4.72 4.40 
9 
5.  Follow the family’s request not to discuss death with a dying 
patient who asks about dying. 
4.66 4.29 
10 
12.  Provide care that does not relieve the patient’s suffering 
because the physician fears that increasing the dose of pain 
medication will cause death. 
3.95 4.51 
11 




16.  Follow the family’s wishes for the patient’s care when I do not 
agree with them, but do so because of fears of a lawsuit. 
2.51 3.70 
13 
7.  Continue to participate in care for a hopelessly ill person who is 
being sustained on a ventilator, when no one will make a decision 
to withdraw support. 
2.49 3.90 
14 
19.  Ignore situations in which patients have not been given 
adequate information to insure informed consent. 
2.37 3.67 
15 
13.  Follow the physician’s request not to discuss the patient’s 
prognosis with the patient or family. 
2.29 3.62 
16 
10.  Be required to care for patients I don’t feel qualified to care for. 
2.26 3.10 
17 
8.  Avoid taking action when I learn that a physician or nurse 
colleague has made a medical error and does not report it. 
1.71 3.06 
18 
11.  Witness medical students perform painful procedures on 
patients solely to increase their skill. 
1.63 2.95 
19 
14.  Increase the dose of sedatives/opiates for an unconscious 
patient that I believe could hasten the patient’s death. 
1.31 2.50 
20 
15.  Take no action about an observed ethical issue because the 
involved staff member or someone in a position of authority 






Professional Moral Courage Scale (PMCS)  
The Professional Moral Courage Scale (PMCS) total score was defined by the average of 
Moral Agency Score, Multiple Values Score, Endures Threat Score, Goes Beyond Compliance 
Score, and Moral Goal Score.  Each subscale score was defined by the average of the three items 
within the category with a range of 1, ‘never true’ to 7, ‘always true’ with 4, ‘sometimes true’ as 
a midpoint (Sekerka et al., 2009).  In this study, PMCS subscale scores ranged from a low 2.67 
to high 7.00 points, with mean scores varying from 5.8 (SD=1.04) to 6.37 (SD=0.63) indicating 
an ability to respond to challenges with courage sometimes to nearly always true.  For example, 
Moral Agency was the highest (M=6.37, SD=0.63) indicating that on average nurses nearly 
always had a predisposition toward the moral behavior and possessed a persistent willingness to 
engage as a moral agent.  The Multiple Value was the lowest score (M=5.8, SD =1.04) 
suggesting that nurses felt less capable in their ability to draw on multiple value sets in moral 
decision making and to effectively sort out and determine what needs to be exercised, and to 
hold firm to beliefs despite external concerns or demands. 
Table 5 shows the descriptive statistics of PMCS Score as well as its five subscales. 
PMCS Score ranges from 4.47 to 7.00 points, with mean = 6.10 and standard deviation =0.60 
(indicating sometimes to nearly always responding to challenges with courage). The skewness of 
PMCS Score is –0.38 (Std Error = 0.18), which means the score is skewed to the left. The 
kurtosis of PMCS Score is –0.58 (Std Error = 0.35). 
Table 5 
Descriptive Statistics for Professional Moral Courage Scale (PMCS) and Subscale 
 











Moral Agency 187 2.67 4.33 7.00 6.3658 .62612 -.885 .178 .193 .354 
Multiple Values 187 4.33 2.67 7.00 5.7989 1.04236 -.999 .178 .542 .354 
Endures Threat 187 4.00 3.00 7.00 5.8944 .86653 -.526 .178 -.047 .354 
Goes Beyond 187 2.67 4.33 7.00 6.1130 .68798 -.383 .178 -.515 .354 
Moral Goal 187 4.00 3.00 7.00 6.3297 .65033 -1.367 .178 3.569 .354 
PMCS Total Score 187 2.53 4.47 7.00 6.1003 .59524 -.375 .178 -.581 .354 





The chart below is the Histogram of the PMCS Score.  
 
Figure 7. Histogram of PMCS scores shows a negative skewness of the distribution 
Major Study Variables 
A Pearson correlation coefficient was calculated for the relationships between the 
dependent variables and independent variables.  Age was positively correlated with total years 
working as a registered nurse (YRSNRSG) (r = 0.759, p <0.01) and total years working as an 
oncology nurse (YRSONC) (r = 0.533, p<0.01).  YRSNRSG was positively correlated with 
YRSONC (r = 0.630, p <0.01). 
All five subscales of PMCS Score were positively correlated with each other and with 
PMCS score itself at a significant level of 0.01 (p<0.01).  Endures Threat was a weak positive 
correlation with total years in nursing (YRSNURSG) (r = 0.207, p<0.01) indicating a significant 
linear relationship between the two variables.  Nurses with more years of nursing experience 
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tended to respond with moral courage when facing an ethical or moral challenge, both perceived 
threats and real danger with endurance.  PMCS Score was a weak positive correlation with total 
years of oncology experience (YRSONC) (r = 0.149, p<0.05).  Nurses with more years of 
oncology work experience tended to respond to moral challenges with moral courage.  MDS-R 
Score was not correlated with any of the listed variables in Table 6 at a 0.05 significance level. 
Table 6 
Correlation Matrix for Dependent Variables and Key Independent Variables 
Variable 1 2 3 4 5 6 7 8 9 10 
1.Age -          
2.YrsNursg
a
 .759** -         
3.YrsOnc
b
 .533** .630** -        
4.MoralAgency
c
 .010 .011 .097 -       
5.MoralValues
d
 .107 .063 .111 .474** -      
6.EnduresThreat
e
 .139 .207** .125 .421** .351** -     
7.GoesBeyond
f
 .111 .082 .132 .550** .482** .593** -    
8.MoralGoal
g
 .092 .109 .102 .546** .499** .453** .580** -   
9.PMCS
h
 .125 .127 .149* .745** .773** .739** .815** .774** -  
10.MDS-R
i
 -.056 .017 .036 -.031 -.098 .032 -.091 -.011 -.055 - 
Note: 
a
Total years nursing experience, 
b













Professional Moral Courage Scale, 
i
Moral Distress Scale-Revised 
*p< .05; **p < .01. (2-tailed)  
Education level was divided into two groups, ‘BSN and below’ (EDUC_binary =0) and 
‘Above BSN’ (EDUC_binary =1).  The average of MDS-R score for ‘BSN and below’ is 83.71 
(SD = 36.88), indicating higher moral distress and 7.21points higher than that of the ‘Above 
BSN’.  However, an independent samples t-test comparing the mean score of education level of 
the two groups indicated that such a difference was not statistically significant (t (184) = 1.216, p 





MDS-R Mean Scores and Standard Deviations for Education Level.  
                                  EDUC_Binary N Mean Std. Deviation Std. Error Mean 
MEAN (MDS-R)                 .00 















t-test for Equality of Means 









Interval of the 
Difference 
Lower Upper 
MEAN   (MDS-R) 
Equal Variances 
assumed 




































The average of PMCS score for ‘BSN and below’ was 6.09 (SD = 0.62), which was very 
close to that of the ‘Above BSN’ as shown in Tables 9 and 10.  The latter had a mean of 6.11 
(SD = 0.55).  The t-test indicated that there was no statistically significant difference of PMCS 
score between the two Education groups (t (184) = - .287, p = 0.774).   
Table 9 
PMCS Mean Scores and Standard Deviations for Education Level  
                                  EDUC_Binary N Mean Std. Deviation Std. Error Mean 
MEAN (PMCS Score)      .00 



















t-test for Equality of Means 









Interval of the 
Difference 
Lower Upper 
MEAN   (PMCS Score) 
Equal Variances 
assumed 




































The average of MDS-R score for the nurses with certification in oncology (ONCCERT 
=1) was 83.12 (SD = 37.11), indicating more moral distress or about 10 points higher than the 
nurses without certification in oncology (M = 73.94, SD = 37.51).  The t-test indicated that there 
was no statistically significant difference of MDS-R score between the two groups (t (185) = -
1.288, p = 0.199).  See Tables 11 and 12.  
Table 11 
MDS-R Mean Scores and Standard Deviations for Oncology Certification 
                                       ONCCERT N Mean Std. Deviation Std. Error Mean 
MEAN      (MDS-R)           0 




















t-test for Equality of Means 









Interval of the 
Difference 
Lower Upper 
MEAN   (MDS-R) 
Equal Variances 
assumed 







































The average of PMCS score for the nurses with certification in oncology (ONCCERT =1) 
was 6.11 (SD =0.58), about 0.06 points higher than the nurses without certification in oncology 
(M = 6.05, SD = 0.66).  The t-test indicated that there was no statistically significant difference 
of PMCS score between the two groups (t (185) = -.557, p = 0.578) as shown in Tables 13 and 
14.    
Table 13 
PMCS Mean Scores and Standard Deviations for Oncology Certification  
                           ONCCERT N Mean Std. Deviation Std. Error Mean 
MEAN  (PMCS Score)       0 



















t-test for Equality of Means 









Interval of the 
Difference 
Lower Upper 
MEAN   (PMCS Score) 
Equal Variances 
assumed 




































The average MDS-R score for the oncology nurses who work in an inpatient work setting 
(Inpatient_binary=1) is 90.96 (SD = 39.62) or 14 points higher than nurses in an outpatient work 
setting (Inpatient_binary=0).  The latter had an average MDS-R score of 77.04 (SD = 34.88).  
The t-test indicated a statistically significant difference of MDS-R score between the two groups 
(t (180) = -2.475, p = 0.014).  See Tables 15 and 16.  
Table 15 
MDS-R Mean Scores and Standard Deviations for Inpatient and Outpatient Worksetting  
Inpatient_binary N Mean Std. Deviation 
Std. Error 
Mean 
MEAN (MDS-R )               .00 




















t-test for Equality of Means 








Interval of the 
Difference 
Lower Upper 
MEAN   (MDS-R) 
Equal Variances assumed 





























The average of PMCS score for the nurses with inpatient work setting 
(Inpatient_binary=1) was 6.08 (SD = 0.63), about 0.03 points lower than the nurses in outpatient 
or other work settings in oncology (Inpatient_binary=0).  The latter had an average PMCS score 
of 6.11 (SD = 0.57).  The t-test indicated that there was no statistically significant difference of 
PMCS score between the two groups (t (180) = .333, p = 0.740).  See Tables 17 and 18.  
Table 17 
PMCS Mean Scores and Standard Deviations for Inpatient and Outpatient Work setting  
Inpatient_binary N Mean Std. Deviation 
Std. Error 
Mean 
MEAN (PMCS )                        .00 



















t-test for Equality of Means 









Interval of the 
Difference 
Lower Upper 
MEAN   (PMCS) 
Equal Variances 
assumed 




































The average of MDS-R score for nurses with End-of-Life Nursing Education Consortium 
(ELNEC) course (ELNEC = 1) was 84.3 (SD = 38.90) or 4.77 points higher than nurses with no 
ELNEC course (ELNEC = 0).  Those with no ELNEC course had an average MDS-R score of 
79.54 (SD = 36.09) as shown in Table 19.  The t-test indicated that there was no statistically 
significant differences between the two groups (t(185) = -.862, p = 0.390).  See Table 20. 
Table 19 
MDS-R Mean Scores and Standard Deviations for End of Life Nursing Education (ELNEC) 
ELNEC N Mean Std. Deviation 
Std. Error 
Mean 
MEAN (MDS-R )                          0 




















t-test for Equality of Means 









Interval of the 
Difference 
Lower Upper 
MEAN   (MDS-R) 
Equal Variances 
assumed 




































The average of PMCS score for nurses with ELNEC course (ELNEC = 1) was 6.13 (SD 
= 0.60) or 0.05 points higher than nurses with no ELNEC course (ELNEC = 0).  Those with no 
ELNEC course had an average PMCS score of 6.08 (SD = 0.59).  The t-test indicated that there 
was no statistically significant differences between the two groups (t(185) = -.538, p = 0.591. See 
Tables 21 and 22.  
Table 21 
PMCS Mean Scores and Standard Deviations for End of Life Nursing Education (ELNEC)  
ELNEC N Mean Std. Deviation 
Std. Error 
Mean 
MEAN (PMCS)                             0 




















t-test for Equality of Means 









Interval of the 
Difference 
Lower Upper 
MEAN   (PMCS) 
Equal Variances 
assumed 





































The average MDS-R score for the group of nurses who had integrated Basic Ethics 
Education into their nursing program was 79.07 (SD=35.71).  The average MDS-R score for the 
group of nurses who had a Separate Ethics Course was 93.40 (SD=36.73), which was the highest 
group.  The average MDS-R score for the group of nurses who had No Ethics content in their 





MDS-R Mean Scores and Standard Deviations for Basic Ethics Education  
 
N Mean Std. 
Deviation Std. Error 
95% Confidence 











































The ANOVA test results indicate that there was no significant difference of the MDS-R 
score among the nurses with different Basic Ethics Education background (F (2,184) = 2.75, p = 
.067).  The ANOVA results are displayed in Table 24. 
Table 24 
ANOVA for MDS-R Scores and Basic Ethics Education  














The ANOVA test results indicated that there was no significant difference of the PMCS 
score among the nurses with different Basic Ethics Education background (F (2,184) = 0.252, p 





PMCS Mean Scores and Standard Deviations for Basic Ethics Education  
PMCS N Mean Std. 
Deviation Std. Error 
95% Confidence 












































ANOVA for PMCS and Basic Ethics Education  














An independent t-test was calculated comparing the mean score for MDS-R and PMCS 
of participants who identified themselves as taking continuing ethics education (ETHICSCEU = 
1) to the mean score of participants who did not take continuing ethics education (ETHICSCEU 
= 0).  The results indicated that there was no impact on MDS-R and PMCS scores and whether 
the participants had taken continuing education courses in bioethics or not.  The results are 





MDS-R Mean Scores and Standard Deviations for Ethics Continuing Education Units (CEU)  
ETHICCEU N Mean Std. Deviation 
Std. Error 
Mean 
MEAN (MDS-R)                           0 











Independent Samples T-test for MDS-R Scores and Ethics Continuing Education Units (CEU) 
ETHICCEU 
Levene’s Test 
for Equality of 
Variances 
t-test for Equality of Means 
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PMCS Mean Scores and Standard Deviations for Ethics Continuing Education Units (CEU)  
ETHICCEU N Mean Std. Deviation 
Std. Error 
Mean 
MEAN (PMCS)                             0 













Independent Samples T-test for PMCS Score and Ethics Continuing Education Units (CEU)  
ETHICCEU 
Levene’s Test 
for Equality of 
Variances 
t-test for Equality of Means 
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An independent samples t-test was calculated comparing the mean score of participants 
who requested or took part in an ethics consult (ETHICSCON=1) to the mean score of 
participants who did not request or participate in an ethics consult (ETHICSCON =0).  The 
results indicated that there was no impact on MDS-R (Tables 31 and 32) and PMCS scores 
(Tables 33 and 34) and whether the participants requested or participated in ethics consult or not 
(t(183) = -1.239, p = .217) and (t(183)  = -.723, p = .471) respectively. 
Table 31 
MDS-R Mean Score and Standard Deviation for Participated or Requested Ethics Consult  
ETHICSCON N Mean Std. Deviation 
Std. Error 
Mean 
MEAN (MDS-R)                           0 



















t-test for Equality of Means 
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Equal Variances 
assumed 





































PMCS Mean Scores and Standard Deviations for Participated or Requested Ethics Consult  
ETHICSCON N Mean Std. Deviation 
Std. Error 
Mean 
MEAN (PMCS)                           0 
















t-test for Equality of Means 
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Quantitative Analysis for Main Research Questions 
The five quantitative research questions (RQ) posited for this study and analyses are 
discussed below. 
RQ1 
Is there a difference between oncology nurses in adult inpatient and outpatient settings 
with respect to their moral distress and moral courage? 
To address research question one, independent sample t- tests were conducted for MDS-
R scores and PMCS scores relative to inpatient (inpatient_binary = 1) and outpatient 
(inpatient_binary = 0) settings.  The results indicate that oncology nurses working in adult 
inpatient setting had significantly higher Moral Distress than oncology nurses in outpatient 
setting.  These results were presented previously in Table 15 and Table 16.  
RQ2  
Among oncology nurses, to what extent, if any, are moral distress and moral courage 
related? 
Research question two was assessed using correlation analysis.  A Pearson correlation 
matrix was obtained to examine the relationships between Moral Distress Scores, Professional 
Moral Courage Scores, and Professional Moral Courage Subscales.  The correlation matrix was 
presented already in Table 5.  No significant correlation was found between the Moral Distress 
score and Professional Moral Courage Score and PMCS Subscales.  The Pearson’s correlation 
between MDS-R score and PMCS score was r = – 0.06, (p = 0.45).  The Pearson’s correlations 
between MDS-R score and PMCS subscales are all weak and not statistically significant (-0.1 
<r<0.1 and p>0.05).   
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A Pearson’s correlation was calculated by inpatient setting examining the relationship 
between participants’ MDS-R scores and PMCS scores.  A weak correlation that was not 
significant was found (r = .129, p =.386).  A Pearson’s correlation was calculated by outpatient 
setting examining the relationship between participants’ MDS-R scores and PMCS score.  A 
weak correlation that was not significant was found (r = -.165, p = .147).  There is no 
relationship between levels of Moral Distress and scores on the Professional Moral Courage 
Scale regardless of work settings.  Even though not significant, the MDS-R scores for inpatient 
group were positively correlated and the outpatient group was negatively correlated.  
RQ3 
What is the level of moral distress as reported by oncology nurses who report moral 
distress residue described as having left a previous job, considered leaving a previous job but 
stayed, or considering leaving a current job now? 
To address this question, first, the participants were split into three groups as shown 
below in Table 35 based on their responses to the following two survey questions: 
1.  Have you ever left or considered quitting a clinical position because of your moral 
distress with the way patient care was handled? 





Description of the Three Groups for Moral Distress Residue 
 CURRENTQUIT = 1 CURRENTQUIT = 0 
QUITCONSID = 1 
Intent to quit current job now 
(Group 1) 
 
Participants who left a previous job 
Participants who considered leaving previous 
job but stayed 
No intent to quit current job now 
(Group 2) 
QUITCONSID = 0 
 
Participants who never considered leaving or 
left a previous job 
No intent to quit current job now 
(Group 3) 
 
The average MDS-R scores for Group 1 was 94.28 (SD=38.88), Group 2 was 85.26 (SD-
40.03), Group 3 was s 72.11 (SD 31.93) as shown in Table 36.  Group 1 had the highest average 
MDS-R score (M=94.28, SD=38.88) suggesting that both previous levels and repeated 
encounters of moral distress are associated with moral distress residue. 
Table 36 
Descriptive Statistics of MDS-R by Group Defined in Table 35  
MEAN (MDS-
R) 
N Mean Std. 
Deviation Std. Error 
95% Confidence 






1-intent to quit 
2- left/consider 



































The ANOVA test showed that there was a significant difference of the mean MDS-R 





ANOVA Results for Comparing MDS-R among the Three Groups 














The analyses indicate a statistically significant difference between the moral distress 
levels among the three groups of oncology nurses.  The oncology nurses in group one who had 
intent to quit their current job had the highest level of moral distress (94 points), about 9 points 
higher than those in group two who had either left a previous job or those that considered leaving 
a previous job but stayed (85 points).  Those who left and considered leaving a previous job but 
stayed scored 13 points higher than group three who neither considered quitting nor left a 
previous job and had no intent to quit a current job now (72 points). 
RQ4a  
Which nurse characteristics are significant predictors of moral distress in oncology 
nurses?   
To examine the categorical predictors in research questions 4 and 5, dummy coding was 
used for dichotomous variables with two categories and effects coding was applied to more than 
two categories (k-1 dummy variables for k categories).  A stepwise multiple linear regression 
was conducted to determine whether the following characteristics (education level, total number 
of years working as registered nurse, total number of years working as oncology nurse, oncology 
setting, oncology certification, ELNEC education, ethics education, and participation in ethics 
consult) were predictors of moral distress score.  Total number of years in nursing (Yrsnursg) 
and total number of years working in oncology (Yrsonc) were treated as continuous variables.  
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All other variables were treated as categorical variables.  Multiple regression approach was 
identified as an appropriate tool to analyze the data gathered for this research question.  Multiple 
regression methods were used to explore the best fits.  In the stepwise regression, the 
significance level for variable entry is set to be 0.05; the significance level for variable removal 
is set to be 0.10.  (An entry level significance level was also set at 0.10 with a removal 
significance level at 0.15, however no additional predictors were found).  All of the relevant 
independent variables were set as inputs for the auto selection and removal.  The regression was 
first conducted on the original MDS-R score without any transformation.   
The researcher then conducted the regression on the natural logarithm of the MDS-R 
scores (LOGNMDS).  Both regression results yielded the same conclusion that the oncology 
setting (Inpatient or Outpatient) was a significant predictor of the Moral Distress Score in 
oncology nurses.  The Inpatient group had a significantly higher moral distress level than the 
Outpatient group.  The results are presented in Tables 38 and 39.  
Table 38 













































Dependent Variable: LogNMDS 
Though the difference of the moral distress level between the Inpatient and Outpatient 
groups was statistically significant (F(1,134) = 6.161, p = .014), with an R
2
 of .044.  The small 
R
2
 values (0.044 for original MDS-R in Table 40, and 0.046 for the transformed LogNMDS in 
Table 41) yielded from the regression models indicated that only a trivial percentage of the moral 
distress score variance could be accounted for by the nurse’s oncology setting.  This suggests 
that other variables could have been significant but data were not collected. 
Table 40 
Regression Model Summary with the Original MDS-R (without Transformation) 
Model R R Square 
Adjusted R 
Square 









 .044 .037 42.43964 .044 6.161 1 134 .014 
a. Predictors: (Constant), Inpatient_binary 
Table 41 
Regression Model Summary with Transformed MDS-R (LogNMDS) 
Model R R Square 
Adjusted R 
Square 









 .046 .039 .60687 .046 6.499 1 134 .012 
a. Predictors: (Constant), Inpatient_binary 
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Normality was assessed through examination of the histogram.  The histogram in Figure 8 
shows that the unstandardized residuals are asymmetrical and somewhat skewed to the left 
(negatively skewed distribution).  
 




 The assumption of linearity was assessed by examining the residual scatterplot.  The 
scatterplot in Figure 9 show the points are somewhat evenly distributed. The findings contain 
minimal violations of linearity which may weaken the regression analysis; however it does not 
invalidate the results (Tabachnick & Fidell, 2007).  It is also reasonable to expect some slight 
departures from the ideal situation due to sampling fluctuations (Tate, 1992).  
 
Figure 9.  Scatterplot unstandardized residual for MDS-R scores. The residuals are somewhat 
evenly dispersed  
Research question four was modified post hoc to add Moral Distress Residue as reported 
by nurses who left a previous job/or considered leaving but stayed (QUITCONSID) to assess if a 
better predictive model of MDS-R score could be established. 
RQ4b  
Which of the following characteristics (education level, total number of years working as 
registered nurse, total number of years working as oncology nurse, oncology setting, oncology 
74 
 
certification, ELNEC education, ethics education, participating in ethics consult, Left or intent to 
leave previous job, and intent to leave the current job) are significant predictors of moral distress 
in oncology nurses? 
The total numbers of years in nursing and total numbers of years working in oncology are 
continuous variables.  All other variables were treated as categorical variables.  Multiple 
regression approach was identified as an appropriate tool to analyze the data gathered for this 
research question.  The stepwise multiple linear regression yielded a more predictive model for 
MDS-R score with two predictors: (1) QUITCONSID (Left a previous job or considered leaving 
but stayed); and (2) Inpatient_binary (the inpatient work setting).  With this regression model 
with two predictors, R
2
 = 0.116 as shown in Table 42 and 43.  This model accounted for 11.6% 
of the moral distress score variance (p= .013) compared with 4.4% using the single predictor (p= 
.014) shown in the original research question and model in Table 40. 
Table 42 
Multiple Regression Model Summary MDS-R with Predictors Moral Residue and Work Setting  
Model R R Square 
Adjusted R 
Square 































a. Predictors: (Constant), QUITCONSID 






Stepwise Multiple Regression on MDS-R with predictors Moral Residue and Work Setting 
Model Unstandardized Coefficients 
Standardized 
Coefficients 

































Which of the following nurse characteristic (education level, total number of years 
working as registered nurse, total number of years working as oncology nurse, oncology setting, 
oncology certification, ELNEC education, ethics education, and participating in ethics consults) 
are significant predictors of professional moral courage in oncology nurses? 
The independent variables, total numbers of years in nursing and total numbers of years 
working in oncology are continuous variables.  All other independent variables were treated as 
categorical variables.  Multiple regression approach was identified as an appropriate tool to 
analyze the data gathered for this research question.  Several approaches were tested to explore 
the best fit.  In the stepwise regression, the significance level for variable entry is set to be 0.05; 
the significance level for variable removal is set to be 0.10.  (An entry level significance level 
was also set at 0.10 with a removal significance level of 0.15; however no additional predictors 
were found).  All the relevant independent variables were set as inputs for the auto selection and 
removal.  The regression was first conducted on the original PMCS score without any 
transformation.  The researcher then conducted the regression on the natural logarithm of the 
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PMCS scores, (LOGNPMC).  The regression result for LOGNPMC was quite similar to those 
yielded in the PMCS regression.   
The regression model for PMCS and total years working in oncology in Table 44 show 
that a significant regression equation was found (F (1, 163) = 4.171, p = .043), with an R
2
 of 
.025.  Participants’ predicted PMCS score is equal to 5.943 + .010 (total years working in 
oncology) when total years working in oncology is measured in years.  The participants PMCS 
score increased .010 points for each year working in oncology.  
Table 44 





















With this model R
2 
= .025 accounted for 2.5% or an inconsequential amount of the 
variance in oncology nurse professional moral courage as shown in Table 45. 
Table 45 
Regression Model Summary for PMCS and Years of Oncology Experience 
Model R R Square 
Adjusted R 
Square 









 .025 .019 .59165 .025 4.171 1 163 .043 
a. Predictors: (Constant), YRSONC 
The regression unstandardized residuals of LogNPMC shown in Figure 10 Histogram 
indicates a fairly normal distribution.  The assumption of linearity was assessed with the residual 
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scatterplot (Figure 11).  The findings contain minimal violations of linearity which may weaken 
the regression analysis; however it does not invalidate the results (Tabachnick & Fidell, 2007).  
It is reasonable to expect some slight departures from the ideal situation due to sampling 
fluctuations (Tate, 1992). 
 





Figure 11. Scatter plot of the unstandardized residuals LogNPMCS show points evenly above 
and below the line. 
Other Morally Distressing Situations  
The Moral Distress Scale –Revised permits respondents to add at least two other 
situations in which they experienced moral distress and score them.  Fifty-six respondents added 
a total of 60 items that were morally distressing as shown in Table 46.  Of these additional items, 
a majority corresponded to existing categories on the MDS-R.  These categories were futile or 
medically inappropriate treatments, poor communication, inappropriate pain management, and 
staffing and safety concerns.  There were seven additional items that potentially address new 
categories of moral distress.  For example, lack of care due to patient health illiteracy, not 
providing best care to a dying patient when no family present, patient and family lacking 
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spiritual sensitivity, failure to consult palliative care or hospice, not enough time to spend with 
patients due to computer charting, and inadequate equipment or supplies to ensure safe patient 
care.  Due to the variability of responses, frequency and intensity scores could not be computed 
for these results.   
Table 46 
Other Morally Distressing Situations (N= 60)        
Number of 
Responses 
Other Morally Distressing Situations Corresponding 
MDS-R 
2 Transporting imminently dying patients to free up a critical care 
bed 
1 
2 Medicaid patients sent to another outpatient center  1 
2 Insurance companies dictating patient treatment based on cost  1 
2 Poor care to cancer patient incarcerated 1 
1 Clinical trial not being offered due to time constraint/enrollment  1 
1 Insurance issues uninsured or underinsured 1 
1 Too many patients not enough time 1 
1 Indigent patients not receiving standard care 1 
1 Valuing speed over accuracy/patient safety 1 
1 Supervisors put their own interest above the staff and patients 1 
1 Physician unable to communicate severity of illness/afraid to tell 
the family the truth 
2 
6 Patients want to continue chemotherapy when treatment is futile 3 
1 Failure of family to recognize dying patient/disagree on EOL 
decisions 
3 
5 Performing CPR on patient at end of life 4 
2 Providers refuse to order appropriate intervention 9 
1 Failure to diagnose and refer patient early for treatment 9 
3 Inadequate pain medication or comfort to dying patient 12 
1 Punished by leadership for reporting ethical issue 15 
1 Not following NCCN guidelines 15 
2 Family has false hope despite being told patient was terminal  16 
1 Discontinuing feeding tube to let patient die 16 
2 Family expecting a miracle 16 
2 Delivering grave news without compassion or answering questions 18 
6 Inadequate staffing/assigned too many patients for safe care 21 
1 Inadequate staff training and orientation to new technology 21 





Other Morally Distressing Situations Corresponding 
MDS-R 
3 Failure to consult palliative care or hospice for pain control 0 
2 Not enough time to spend with patient due to computer charting  0 
1 Lack of care due to low health illiteracy 0 
1 Not providing best care to a dying patient when no family present 0 
1 Patient and family lack spiritual sensitivity 0 
1 Misuse of federal grant 0 
1 Inadequate equipment/supplies 0 
N=60 Items corresponding to MDS-R 1-21. Items not corresponding = 0  
 
Qualitative Data Analysis 
RQ6 
What actions are indicative of moral courage?   
To examine this qualitative question, respondents were asked specifically, “If you 
experienced a morally challenging situation, describe how you took a stand for your patient; 
what was the outcome of your stand; how did that make you feel?”  Seventy-six (41%) of the 
participants provided responses, ranging from very short to detailed, poignant descriptions.  A 
pragmatic qualitative approach was used for content analysis and described as an “approach of 
empirical, methodological controlled analysis of text within its context of communication, 
following content analytic rules and step by step models without rash quantification” (Mayring, 
2000, p.5).   Pragmatic knowledge in this context can be understood as established principles, 
heuristics, and rules guiding the actions and decisions of the researcher during different steps of 
the assessment process (Schilling, 2006).  In Figure 12, the pragmatic qualitative content analysis 




Figure 12.  Qualitative content analysis.  
Level 1. From written texts to raw data.  The written texts were downloaded from the 
Qualtrics database into an Excel spreadsheet table, then sorted and organized around five 
headings (raw data, moral challenge, moral courage/stand, feelings, and outcomes) to align with 
existing categories of moral distress and moral courage frameworks guiding this study.  In this 
context, the raw data were examined and content was extracted and matched to one of the four 
remaining headings.  The researcher did not use open coding to uncover new concepts given the 
scope of specific responses to the research question.  All texts were anonymous and no attempts 
were made to link opinions of participants toward a certain region or institution or to a response 
to the questionnaire portion of the instruments.  
Level 2. From raw data to the condensed procedure.  The main dimensions for 
categorizing data from the research question were reduced to a meaningful element or segment 
of text comprehensible by itself, containing one idea, and episode or piece of information (Tesch, 
Level 1: from 
written texts to raw 
data 
Level 2: from raw 
data to condensed 
procedure 




Level 4:  from 
preliminary category 
to  coded  procedure 





1990 as cited in Schilling, 2006) to enable an answer-focusing strategy (Schilling, 2006).  
Statements that were not important to answering the question were set aside.  Next, the text was 
paraphrased, deleting all words not necessary to understand the statement, transforming the 
sentences into a short form.  For example, “it was important to support patient autonomy” was 
categorized as “supporting patient’s decision; respecting autonomy.”  An independent control 
check was done by the research adviser (independent researcher) who has qualitative experience.  
Level 3. From condensed to structured procedures and preliminary categories.  
Structuring permits each statement to be attached to one of the defined preliminary category 
(moral challenge, moral courage/taking a stand, feelings, and outcomes of taking a stand).  In 
this example, “supporting patient’s decision” was a category aligning with moral courage/taking 
a stand.  Interrater reliability was checked by the research adviser who made recommendations 
and reorganized content to form new categories that emerged from the data to ensure that each 
statement represented a single idea.  Any case in doubt was checked against the original data 
resulting in 100% agreement.   
Level 4. From a preliminary category to coded procedures.  The five dimensions of 
Professional Moral Courage (Sekerka, Bagozzi and Charnigo, 2009) were used as the framework 
to provide the preliminary set of codes and formal definitions for the content category.  The 
definitions were derived from theory and prior research to build the content category labels and 
themes or subcategories.  Themes and subcategories derived from the condensed statements in 
level three were aligned with the five dimensions of Professional Moral Courage (Moral Agency, 
Multiple Values, Endures Threat, Goes Beyond Compliance, and Moral Goal).  For example, the 
subcategory and emerging theme “supporting” and “risk taking” were aligned with Moral 
Agency.  Nurses who support, advocate for, and risk consequences to ensure patients’ 
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preferences and choices are followed demonstrate moral agency.  If a statement implied or 
demonstrated empowerment, it was classified as Multiple Values.  Nurses who empowered their 
patients demonstrated an ability to draw on multiple value sets such as sharing information, 
sharing power, or problem solving in moral decision making and effectively sorting out and 
applying strategies while holding firm to beliefs despite external concerns or demands (Sekerka 
et al., 2009).   
When additional concepts emerged from the data related to the five elements of the 
Professional Moral Courage scale, they were linked to the most appropriate large category and 
further expanded to develop the conceptualization of the category.  This extended the 
subcategories/themes corresponding to the segment of text resulting in 12 themes, thus 
supporting the data.  The researcher and research adviser agreed 100% with the final categories 
and themes.  A summary of the coding category is presented in Table 47 in Appendix I.  
Statements that could not be categorized “misfit analysis” were analyzed.  The misfit analysis 
(n=10, 7.6%) did not exemplify moral courage or could not be categorized because no response 
was provided.  Nevertheless, a moral challenge or situational factor that affects the nurse’s 
ability to act was identified by one participant who stated, “Due to being employed at that time 
by a six-physician Medical Oncology office I was not able to address my concerns”.  In this 
example, lack of administrative support was associated with the moral challenge and inhibited 




Level 5: Concluding analyses and interpretation.  Finally, data were used to develop an 
enhanced view of the five categories used for the Professional Moral Courage Scale (Sekerka et 
al., 2009).  These concepts and a view of the larger experience of Moral Courage are presented in 
the findings section.   
Qualitative Findings 
In this study, moral courage was preceded by a morally challenging situation.  When 
asked to describe a morally challenging situation that led to moral courage, the top four most 
frequent responses clustered under patients’ perspectives or wishes not being heard, futile 
treatment, poor pain control and poor provider collaboration/communication.  A unifying 
principle demonstrated by the oncology nurses was respect for the inherent dignity of patients 
and respect for their decisions which was captured within the context of their statements.  Moral 
distress was triggered by the threat or violation to the fundamental principle that underlies 
nursing practice.  In these circumstances, nurses were aware of their duty to preserve, protect, 
and support the rights of the patient.  A unique finding from the perspectives of the nurses was 
that patients’ wishes and preferences to stop or forgo treatment were not honored by the family 
or provider.  One nurse was distressed about following the family wishes instead of the patient’s, 
and family putting pressure on the patient to take treatment even though the patient did not want 
the treatment.  Another patient wanted to stop treatment, but the spouse did not want the patient 
to stop treatment and was pressuring the patient to continue treatments.  A different patient 
confided in the nurse outside the presence of the family that did not want to go through the 
proposed chemotherapy, yet the family pressured the patient to go through with it.  The nurse 
revealed that working on the oncology floor it had become not at all unusual, if not common, to 
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see families making decisions that met their needs rather than the needs of the patient.  The 
qualitative data revealed that different situations of moral distress were encountered by oncology 
nurses in outpatient settings.  Nurses in the outpatient setting reported ethical concerns around 
informed consent and continuing with chemotherapy against the patient’s wishes. 
The final themes are illustrated in the concept map in Figure 13.  The five dimensions of 
moral courage or taking a stand were expanded into twelve recurring themes that exemplified 
moral courage in oncology nurses.  These themes can be used to expand items on the 
Professional Moral Courage Scale or develop a new scale. 
 
 Figure 13. Concept map of moral courage in oncology nurses. 
Moral Agency was defined as a predisposition toward the moral behavior and possessing 
a persistent will to engage as a moral agent (Sekerka Bagozzi, & Charnigo, 2009).  The final 
86 
 
themes were supporting, risk taking, and advocacy were recurring examples of courage 
demonstrated by nurses in the current study.   
Supporting.  In displaying moral courage and standing up for the patient, several nurses 
championed and reinforced behaviors that promoted patients’ autonomy.  Ensuring that the 
“patient received the very best care possible” was a strategy that bolstered the patient and nurse 
relationship.  Nurses considered the individual’s needs and established trust to ensure that the 
patient’s voice was heard.  One nurse stated, “It did not seem like much, but it was all I could 
do.”  The nurse validated the patient’s concerns and encouraged the patient to express her own 
feelings by “explaining each physician’s role in her treatment and reassuring her that I had heard 
everything the doctors had said” in order to help the patient make a decision.  The nurse also 
helped other staff appreciate that this was the patient’s will and right.  
Risk taking.  A few nurses demonstrated risk taking behaviors such as confronting the 
physician responsible for providing unwanted continuing care at end-of-life.  Being willing to act 
and taking responsibility is risky.  A nurse revealed that although the physician was upset, it was 
rewarding to stand up for the patient and to see that his needs were met, supporting the patient’s 
end-of-life decisions and stopping the treatment.   
Advocacy.  Oncology nurses demonstrated advocacy by representing and preserving their 
patient’s best interest and upholding their patients’ wishes and preferences informing family 
about current status and level of discomfort, listening to the patient, obtaining the information 
needed by the patient to make decisions, and assessing the patient’s current status to 
communicate openly to the physician(s).  One nurse explained to the patient it was her right to 
dictate the care she wanted and she did not have to take it. The patient did not want it “I walked 
her back to the physician’s side so she could talk to him.”  
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Moral courage was shown in nurses who incorporated supporting, risk taking, and 
advocacy interventions to assure the patient’s voice was heard and acted upon to promote 
responsible and appropriate decision making including minimizing unwanted or unnecessary 
treatment and suffering.  
Multiple Values was described as the ability to draw on multiple value sets in moral 
decision making while effectively sorting out and determining what needs to be done, holding 
firm to beliefs despite external concerns or demands (Sekerka et al., 2009).  Despite having 
moral distress, oncology nurses were resourceful and driven to do the right thing. Four recurring 
themes were observed. 
Enlarging the circle for decision-making.  Oncology nurses demonstrated a guiding set of 
principles through communication and collaboration to enlarge the circle of decision-making.  
For example, moral courage was displayed by one nurse who contacted the patient’s medical 
doctor who agreed to take over the patient’s end-of-life care from the oncologist.  Another nurse 
consulted a physician who was of the patient’s nationality to speak with the family, then with the 
patient to ensure that the patient received informed consent for treatment with a full 
understanding of the cancer diagnosis and prognosis.  Several nurses requested and consulted 
with the ethics committee.  One nurse corralled the various medical staff and nursing staff caring 
for the patient, including social worker and requested an ethics committee meeting.  
Beyond personal values.  Nurses who showed courage recognized their own emotions 
and put their personal beliefs aside during the conflict to encourage the patient and family to 
communicate.  One nurse said she respected the patient’s decision to continue treatment, even 
though “I did not agree.”  Another nurse spent additional time with the patient to educate her on 
the disease type and all possible treatment options and potential side effects in order to make an 
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educated decision even though the nurse personally did not agree with the patient, “it was her 
right to make this decision.”  
Patient autonomy.  Moral courage was revealed by the nurse promoting patient autonomy 
and encouraging the patient “to talk to her family and doctor about what she wanted.” The nurse 
emphasized, “I talked with her about it first because she brought it up, she seemed frail, tired, 
and scared; and I sensed that she might not have made her own feelings clear to her family.  She 
ended up going through treatment.” Nurses preserve and protect patients’ rights by assessing 
their understanding of information and explaining the implications (ANA, 2015).  
Patient empowerment.  Oncology nurses demonstrated moral courage by empowering 
their patients to make decisions.  One nurse reflected on the dying process and asked the family 
to put themselves in their loved one’s shoes and to consider dying in pain and suffering as death 
was imminent and it was a choice to die with or without pain.  The nurse recognized that respect 
for human dignity begins with patients taking responsibility and being empowered to make 
decisions without the control of others and enhancing the patient’s ability to act autonomously 
(ANA, 2015; Anderson et al., 1995). 
Enlarging the circle for decision making, beyond personal values, patient autonomy, and 
patient empowerment were approaches used by nurses that demonstrate moral courage.  Moral 
courage in this example arises from an understanding that integrity preserving compromise 
around patient decision-making involves multiple individuals to assure fair and transparent 
conflict resolution (ANA, 2015). 
Enduring Threat was defined as facing an ethical and moral difficulty, including both 
perceived and real danger with endurance (Sekerka et al., 2009).  Oncology nurses endured 
89 
 
threats for their patients by standing up to power in the face of consequences in a complex 
system and by conquering their fears.  
Fighting for my patient in face of consequences in a complex system.  In this example a 
few nurses exemplified moral courage.  After reading the package insert the nurse was 
uncomfortable giving the medication in the outpatient setting because the risk for reaction was 
great and discussed the concern with the manager who felt it was safe and therefore “we” were 
going to give it.  The nurse refused to give the therapy and did not obtain the patient’s consent.  
However, the other nurses moved forward and gave the drug.  Within 30 minutes the patient had 
a reaction and was sent to the hospital.  In a different scenario, the nurse called the physician and 
refused to give the drug.  The physician called administration but the nurse was supported by her 
manager and administration.  In another example, the threat escalated to a real danger when the 
nurse called the legal department to support the written and verbal wishes for care communicated 
by the patient and spouse as healthcare surrogate.  The physician was instructed to abide by the 
patient wishes.   However, the physician was upset and physically knocked the office door off 
the hinges looking for the nurse.   
Conquering fear.  In addition to assessing the ethical principle at stake (autonomy, 
beneficence, non-maleficence, fidelity and justice), nurses frequently draw on inner strength and 
prayer to conquer fear before taking a stand.  While experiencing a morally challenging situation, 
“I decide to take or not take action.”  Before deciding, the nurse took a deep breath, prayed and 
answered according to the patient’s conditions and needs, “she [the patient] had terminal 
metastatic colon cancer and was suffering intractable pain without relief.”  “The children had a 
meeting with their mother and later that day they chose comfort measures only.  The patient 
received alleviation and died with dignity surrounded by her family members.”  Doing the right 
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thing for the patient was balanced by the nurses’ obligation and awareness of the moral and 
ethical rights of the individual.  
Going Beyond Compliance was defined as one who not only considers the rules, but also 
reflects on their purpose, goes beyond compliance-based measures to consider what is right just, 
and appropriate (Sekerka et al., 2009).  Sharing information: getting to the meaning was an 
approach demonstrated by nurses who went beyond compliance. 
Sharing information: getting to the meaning.  Moral courage was exemplified in nurses 
who collaborated with the social worker, other nurses, and members of the palliative care team to 
gain insight or perspective in dealing with family members when handling delicate issues.  In 
general, nurses demonstrate resourcefulness while considering what is right in a tricky situation.  
One nurse revealed such skill by talking honestly about the patient’s wishes and feelings about 
going to the in-patient hospice facility. “We talked and laughed and cried that afternoon/evening.  
Finally I asked her frankly, what do you want to do? Do you have any desire to try chemotherapy 
again?” This nurse set in motion “a lot of very upset administrators, nurses and supervisors” 
because she interrupted what was “their plant to transfer the patient to hospice.”   
Tricky situation.  Handling tricky situations involved diplomacy or ruffling feathers.  One 
nurse told the physician as nicely as possible that “I had his number and I knew he was on call 
the weekend.  I was working all weekend and I would be calling on an hourly basis to advocate 
for the patient who was moaning and writhing in the bed but not awake enough to give me a pain 
level.”  This showed that the nurse was acting within her responsibility and authority but was 
doing so in a way to force change in approach to pain control by a physician. 
Moral Goal was defined as a drive for task accomplishment that includes the use of 
virtues (e.g., prudence, honesty and justice) throughout the decision making process to achieve a 
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virtuous outcome (Sekerka et al., 2009).  Working toward a goal becomes more important than 
the activities themselves. 
Truth telling: protecting the patient.  Truth telling was a positive and common approach 
employed by the nurse signifying the moral goal.  One nurse who had cared for several 
terminally ill and actively dying patients revealed that she was able to discuss with patients their 
thoughts on what they wanted for their care if they suddenly stopped breathing.  The nurse took a 
stand for her patients by explaining the CPR protocol for a patient that becomes unresponsive in 
addition to helping them by discussing end of life wishes.  Another nurse stated, “Before starting 
chemotherapy, I sat down with the patient, and asked him why he wanted to continue with 
therapy and what he expected to achieve by doing so.  The patient had the understanding that he 
could be cured.  I gently explained that the goal of therapy in his condition was palliation but if 
receiving therapy caused him more distress and decreased quality of life, he may want to 
consider forgoing therapy.”  In a different scenario, the nurse was honest and candid and 
suggested some questions for them to ask the physician team.  Promoting advanced care 
planning conversation is within the scope of nursing practice.  Nurses and physicians have an 
ethical and moral responsibility to ensure that patients and their healthcare surrogates receive 
appropriate decision-making support and communication (Melhado & Byers, 2011).  The 
advanced care planning process assures treatment options are discussed including benefits and 
burdens.  The goal is to understand the patient’s values about treatment outcomes and assure 
informed decision-making.  The oncology nurses in this study normalized the experience of 




Oncology nurses showed moral courage in dealing with members of the healthcare team 
and the family to voice patients’ perspectives.  Raising questions about the direction of care 
requires courage.  A common theme expressed by these nurses was valuing patients’ right-to-
decide what kind of care they receive and wanting patients’ wishes to be met, not the family’s or 
physician’s desires.  In a few cases, taking the moral action angered the physician and did not 
accomplish the desired effect from the nurse’s perspective.  Patients sometimes recognize 
nurses’ courage, but that was not required for the nurse to show moral courage.  One patient 
thanked the nurse for her honesty and bravery for going against the physician, “He said to me,” 
“I know you put yourself in a tricky situation but I really appreciate what you have done for me 
[sic].” 
 Expression of Feelings and Reflections  
One nurse in an outpatient setting was distressed administering chemotherapy to a patient 
with advanced Alzheimer’s but could not address her concerns due to repercussions and working 
in a small oncology practice.  Another nurse shared that despite undergoing several 
chemotherapies and procedures for terminal metastatic colon cancer, “the patient suffered 
intractable pain unrelieved by the palliative treatments”.  In that scenario, the children were 
distressed by the patient’s pain and suffering and asked the nurse, “what they should do” and 
whether or not the nurse would continue treatment.  Although oncology nurses in this study 
empowered their patients and engaged other members of the team to help in communication, 
some nurses have perceived emotional threats as they took moral action.  Nurses who took a 
stand but could not complete the transaction or morally correct action expressed a sense of failed 
advocacy, fear, anger, frustration, guilt, insomnia, discomfort, and emotional pain.  One nurse 
who did not speak up about a patient’s perceived futile treatment felt angry, “because it appeared 
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that the physician let ego play a part in the ability to defeat this disease and no one spoke at all 
about quality of life, and that was wrong.”  Another nurse reported that the experience was 
emotionally painful to watch a patient suffer from persistent pain, watch nursing staff suffer 
emotionally from watching a patient suffer, and dealing with personal feelings of not advocating 
more for the patient. 
Nurses who took a stand for the patient had a different reaction.  These nurses reflected 
on their experiences in a positive manner and felt relief, satisfaction, less stress, pride, and 
happiness.  One nurse reported that it was easier and less draining for the staff when everyone 
was on the same page.  Another summed up courage as the importance of nurses’ role in patient 
care, taking action, and honoring patients by taking the right action.  Taking a moral stand 
requires ethical competence and a supportive ethical climate whereby nurses can carry out their 
principled obligations to the patient.   
While no attempt was made to match the qualitative responses to the quantitative 
responses on the Professional Moral Courage Scale, these findings support that oncology nurses 
do strive to take moral action and practice moral courage.  The multifaceted question posed 
specifically, “if you experienced a morally challenging situation, describe how you took a stand 
for your patient; what was the outcome of your stand?  How did that make you feel?” identified 
morally challenging situations in which nurses took a stand by supporting patients’ decisions, 
empowering patients to ask questions to ensure their voices were heard, risk taking and fighting 
for their patients in the face of consequences, respecting patients’ autonomy, truth telling and 
conquering fear.  The underlying catalyst for the moral distress was not following the patients’ 
wishes and inadequate pain control.  One nurse working in a small oncology practice 
acknowledged distressing clinical situations but did not take a stand because of fear of 
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retribution.  Nurses who demonstrated moral courage also experienced satisfaction, relief, and 







CHAPTER FIVE: DISCUSSION 
 
Discussion of Findings 
Being a full partner in healthcare requires that nurses recognize moral distress and act 
courageously and professionally in addressing morally distressing clinical situations (Institute of 
Medicine, 2011; Pavlish, Brown-Saltzman, Jakel, & Fine, 2014; Pendry, 2007).  Studies on 
moral distress have shown light on nurses’ suffering, yet how these nurses take a stand or 
practice moral courage during times of distress was not clear.  Moral distress can arise when 
nurses’ core values to support, advocate for and protect the health, safety, and rights of the 
patient are threatened (American Nurses Association, 2015; Cohen & Erickson, 2006).  This 
study examined the factors that influenced moral distress and the relationships between moral 
distress, moral courage, and moral distress residue among oncology nurses working in adult 
inpatient and outpatient settings.  It also described actions of moral courage as reported by 
oncology nurses. Although the model tested was not a good predictor of moral distress or moral 
courage, it underscores the presence of moral distress and moral distress residue among oncology 
nurses and the importance of finding ways to lessen moral distress and strengthen moral courage.   
Findings from the qualitative data provide insight about how nurses act courageously in the face 
of morally distressing clinical situations to ensure patients’ voices are heard.  
Moral Distress  
This study highlighted that oncology nurses encounter moral distress when patients do 
not receive honest and ample information about their cancer diagnosis that influence patients’ 
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right to make choices about treatment options.  The three top ranked morally distressing 
responses on the MDS-R provided by oncology nurses capture their sentiments and include 1) 
witnessing healthcare providers giving false hope to a patient or family, 2) witnessing diminished 
patient care quality due to poor team communication, and 3) following the family wishes to 
continue life support even though it was not in the best interest of the patient.   
The independent-samples t test comparing the Moral Distress mean scores of oncology 
nurses in inpatient and outpatient settings found a significant difference between the means of 
the two groups.  Oncology nurses working in inpatient settings had higher levels of moral 
distress than their counterparts in outpatient settings.  Although, the difference in moral distress 
levels between work settings was statistically significant when entered into the regression model, 
it was a weak predictor of moral distress.  This finding may suggest that the MDS-R instrument 
did not encompass all of the sources of moral distress encountered by oncology nurses as 
evidenced by the specific examples reported by the nurses in the study.  Another possible 
explanation is that outpatient oncology nurses may have alleviated moral distress by changing 
from an inpatient setting to a less stressful setting.  Nurses in an inpatient setting tend to 
encounter patients with higher comorbid conditions and poorer outcomes than those achieved in 
an outpatient setting (Lubell, 2012).  Poorer outcomes in hospitalized patients were associated 
with insufficient resources, including inadequately trained personnel (Robinson & Beyer, 2010).  
Even though most chemotherapy is administered in the outpatient setting, patients who 
experience severe side effects often end up in the emergency room or admitted to the hospital.  
For example, many patients experience prolonged hospitalizations and recurrent admissions 
associated with treatment side effects (Fitch & Pyenson, 2010).  Still the work setting accounted 
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for a minuscule portion of the variance suggesting that other factors and personality of the nurse 
need to be considered.   
Though previous studies found significant differences in levels of moral distress between 
professions and work units in which nurses and other direct care providers (physicians, case 
managers, social workers, respiratory therapists) had the highest level of moral distress, work 
unit was not a predictor of moral distress (Allen et al., 2013; Whitehead et al., 2015).  Allen et al 
(2013) reported differences in moral distress across disciplines associated with responsibilities of 
each discipline and work dynamics.  Similar patterns across disciplines were also reported by 
Whitehead et al. (2015) suggesting that levels of moral distress were related to the ethical culture 
and work environment.  Additional studies found high levels of moral distress for nurses 
associated with following the family’s wishes to continue life support even though it was not in 
the patient’s best interest (Allen et al., 2013; Winland-Brown, Chiarenza, & Dobrin, 2010).  
Winland-Brown et al. (2010) reported a significant finding for following the physician’s order 
not to tell the patient the truth when he/she asked for it.  Researchers examining truth telling and 
how physicians inform patients with serious illness of their diagnoses and how much information 
patients want, found that the vast majority of patients responded that they had a right to know 
their condition and to be informed by the provider of a life threatening illness and prognosis 
(Punjani, 2013; Sullivan, Menapace, & White, 2001).  Nurses also believed that patients had a 
right to be told the truth about their illness by the physician (Sullivan, Menapace, & White, 
2001).  Not abiding by patients’ wishes can perpetuate a culture of false hope, power inequality 
and moral distress rather than promote team collaboration and honest communication around the 
patients’ goals and preferences (ANA, 2015; Pavlish, Brown-Saltzman, Fine, & Jakel, 2015). 
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No statistically significant differences were found between nurses’ characteristics (age, 
education level, certification, ELNEC training) and moral distress in this study.  Though nurses 
with a bachelor’s degree had higher Moral Distress scores compared with other levels of 
education, neither education, RN experience, nor oncology certification were found to be 
predictors of moral distress in this study.  Other researchers found significant relationships 
between end-of-life education and moral distress (Whitehead et al., 2015), and level of education 
and moral distress (Sirilla, 2013) but none were predictors of moral distress.  Sirilla (2013) 
reported a negative but significant relationship between moral distress and education level and 
work units, concluding that the addition of separate ethics courses at higher education levels 
yielded greater confidence in decision-making for these nurses.   
In this current study, while oncology nurses who took a separate ethics course had an 
overall higher mean moral distress score than nurses who did not, the ANOVA test results in 
Table 23 indicated that such a difference was not significant.  The post hoc η
2
= .03 was small 
indicating that a larger sample size or a minimum of 53 participants per group was needed to 
achieve statistical significance.  With the convenience of online nursing programs, it is 
speculated that nurses who take separate ethics courses as a requirement of a bachelor or 
graduate degree likely learn within an interdisciplinary environment where sharing of work-
related experiences can provide an opportunity for reflection, feedback, and problem solving.  
Another study examining relationships between ethics education, moral action, and confidence 
found a significant relationship between the variables, suggesting that ethics education positively 
influenced nurses’ confidence in ethical decisions and moral action (Grady, Danis, Soeken, 
O’Donnell, et al. 2008).   
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With ethics education, nurses are aware of their role and responsibility and become more 
distressed when those values do not align with the moral action (Winland-Brown et al., 2010).  A 
similar relationship between moral distress and having taken a prior ethics course was also found 
by Winland-Brown et al. (2010); respondents had a significantly higher amount of moral distress 
compared with those who had not taken any ethics’ courses.  Winland-Brown et al (2010) 
concluded that nurses were likely able to react with the skill set and knowledge when dealing 
with morally distressing situations rather than becoming frustrated or quitting their jobs.  Those 
who take ethics courses are alerted to situations that are unethical and learn conflict resolution 
and how to work through an ethical dilemma or to request an ethics consult.  The type of ethics’ 
education and how the content is assimilated into the work setting raise additional questions.  For 
example abstract concepts and practical applications must be integrated in the practicum and 
clinical rotation so that nursing students and nurses advancing their education have an 
opportunity to discuss ethical situations in the work setting and develop conflict resolution.   
In the current study oncology nurses identified several situations in the work setting that 
were morally distressing by writing in a total of 60 items at the end of the MDS-R scale (see 
Table 46).  Seven items potentially represent and address new categories of moral distress in the 
oncology setting.  These items include: lack of care due to low health literacy; not providing best 
care to a dying patient when no family present; patient and family lacking spiritual sensitivity; 
failure to consult palliative care or hospice; not enough time to spend with patients due to 
computer charting; and inadequate equipment or supplies to ensure safe patient care.   
Additionally, nurses who provided qualitative responses and recounted morally 
distressing situations confirmed previous findings in the literature.  Oncology nurses’ qualitative 
experiences enriched the quantitative findings.  For example, nurses reported a majority of 
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situations in which the patient was pressured by the family or physician to continue 
chemotherapy treatment even though the patient had voiced a desire to stop treatment.  Some 
patients’ wishes and preferences to stop or forgo chemotherapy treatment were not honored by 
the family or physician.  An oncology nurse said, “An elderly woman diagnosed with breast 
cancer felt pressured by the physician to have treatment she did not want.”   Oncology nurses 
also described several situations involving patients that did not want life support at end-of-life 
but, the patient’s wishes or health care surrogate was ignored, prolonging medically 
inappropriate treatments, inadequate pain control, poor provider communication and 
collaboration, delays in discussing prognosis and Do Not Resuscitate orders (DNR), giving false 
hope, patient safety and confidentiality concerns, and improper consent.  Other studies have 
reported similar perspectives whereby the family member minimized patients’ concerns and 
parents directed all the care decisions and either threatened to discontinue insurance or forced the 
older child to sign over decision making rights (Pavlish, Brown-Saltzman, Jakel, & Fine, 2014). 
In this current study, the ethical challenge was the catalyst that activated the moral action.  
Although ethical challenges can provide opportunities to have dynamic and positive 
conversations around patient goals, the presence of moral distress indicates insufficient conflict 
resolution (Epstein & Delgado, 2010).  Nurses have a moral obligation to be familiar with and 






This current study provided a primary focus on moral courage in oncology nurses.  Both 
the quantitative and qualitative findings as experienced by nurses in oncology settings expand 
the science of moral courage and suggest areas to revisit on Sekerka’s et al. (2009) Professional 
Moral Courage Scale [PMCS].  The results show a weak positive significant correlation between 
total years working in oncology and PMCS.  Total years’ working in oncology predicted a small 
amount of the Professional Moral Courage score.  Nurses with more years of oncology work 
experience tend to act with professional moral courage.  One logical inference is that as nurses 
become more experienced and comfortable with administration of chemo drugs and side effects 
they can anticipate what orders are needed and communicate with the physician efficiently.  
Although oncology nurses working in inpatient setting had higher moral distress scores, there 
were no significant differences in PMCS scores related to work settings, which may suggest that 
nurses are aware of their moral obligations regardless of work setting but cannot always take the 
correct moral action.  Inpatient nurses were slightly younger in age (M = 49.6, SD = 10.82, R = 
25-68) compared to those in the outpatient setting (M = 52.7, SD = 9.92, R = 29-79) which may 
suggest that the more mature nurses prefer a shorter work day or over a period of time were less 
concerned about the ramification and risk of standing up with courage.  It is also conceivable that 
inpatient oncology units have a greater turnover of patients and readmissions rates whereby 
greater numbers of morally distressing situations are likely to take place.  Regardless, these are 
complex issues.  No doubt other factors or variables such as leadership support and training in 
moral courage may explain and predict professional moral courage.  How these skills are 
cultivated in the work setting needs further investigation.  
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Raising questions about the direction of care requires courage.  Nurses are frequently in a 
“catch 22” or difficult situation where they witness the emotions of the patient and family for 
which there is no easy solution.  Yet, observing patients suffer because of poorly controlled pain 
became the catalyst for moral action by oncology nurses in this current study.  These nurses 
accepted their moral obligation to advocate for the patient, both educating the family and 
persuading the physician that the patient’s voice needed to be heard.  In this scenario, the nurse 
was assertive and told the physician she would continue to call until the patient’s pain was 
relieved.  As nurses develop a more active voice in collaboration with physicians, assertiveness 
training among nurses might decrease moral distress and enhance moral courage.    
Palliative chemotherapy treatment is unable to cure cancer but intended to decrease 
symptoms, tumor burden, control pain, and prolong life (Houlihan, 2015).  Previous studies 
reported that inadequate pain control for the patient was associated with emotional suffering for 
nurses who were angered and frustrated (Bernhofer & Sorrell, 2015; Pavlish et al., 2014) by the 
physician’s refusal to increase the pain medication.  When patients continue to suffer despite 
nurses’ best efforts to get the right medication and appropriate dose to alleviate pain, studies 
reported that nurses may feel powerless or experience a threat to their own moral integrity 
(Epstein & Delgado, 2010).  Nurse barriers have also been associated with difficulty 
communicating with or obtaining orders from the provider (Bernhofer & Sorrell, 2014).  
Nevertheless, patients have a moral and legal right to have their pain managed and to determine 
what will be done including a choice of no treatment and to be given support through the 
decision making process (ANA, 2015).  Such considerations must respect the patient’s decisions 
and does not require the nurse to agree with or support all choices made by the patient (ANA, 
2015).   
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Even so, findings in this study reveal that oncology nurses who displayed moral courage 
and took a stand also expressed feelings of relief, satisfaction, pride, less stress and personal 
growth.  A fundamental principle demonstrated by oncology nurses in the study was that they 
valued patients’ rights to decide what kind of care they receive and they strived to adhere to the 
patients’ preferences.  A significant finding, total years in nursing experience was a weak 
positive correlation with Endures Threats (subscale) on the PMCS.  This finding may suggest or 
support the idea that nurses with more years of nursing experience may take on the responsibility 
for breaking the bad news.  The oncology nurses who responded to the qualitative question in 
this study provided insight about their moral courage.  These nurses displayed moral virtue and 
had an active role by means of supporting the patient, risk taking, advocacy, enlarging the circle 
for decision-making, putting aside personal beliefs, respecting patient autonomy, empowering 
the patient, fighting for the patient in face of consequences in a complex system, sharing 
information, getting to the meaning, handling tricky situations, protecting the patient and truth-
telling (see Table 47).  This study also revealed that nurses sometimes express justifiable anger at 
physicians who failed to communicate the severity of illness or tell the family the truth.  One 
nurse was honest and candid and suggested some questions for the patient and family to ask the 
physician.  Truth-telling was done in a sensitive and compassionate manner while supporting the 
patient and family.  If the nurse judges that the patient should have information that is the 
physician’s primary responsibility to communicate, and the physician fails to disclose the 
information, the nurse has a moral responsibility either to communicate that information or see 
that the information is communicated to the patient (Jameton, 1984, p. 175).  In addition to 
assessing the ethical principle at stake, the nurse frequently draws on inner strength and prayer or 
the use of spirituality for moral courage, conquering fear before taking a stand.  Doing the right 
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thing for the patient was balanced by the nurses’ obligation and awareness of the moral and 
ethical rights of the individual (ANA, 2015).  
Participants in this study demonstrated moral courage in dealing with members of the 
healthcare team and the patient’s family to give voice to the patient’s perspective.  Nurses 
practice with moral courage when they confront situations that pose a direct threat to patient care 
(LaSala, & Bjarnson, 2010).  Oncology nurses used risk-taking tactics to take a stand.  Such 
action was taken by the nurse who confronted the physician responsible for providing unwanted 
ongoing care at end of life.  Being willing to act and taking responsibility is risky.  One nurse 
revealed that the physician was upset, but it was rewarding to stand up for the patient and to see 
that the needs were met, supporting the patient’s end of life decisions and stopping the treatment.  
Wiegand and Funk (2012) did not measure moral courage, but observed a similar phenomenon 
when some nurses tried to intervene to ensure that patients’ preferences were followed however, 
their voices were not heard.  Though a few nurses were successful in their intervention and 
influenced the patient outcome, a majority said they would not intervene in the future (Wiegand 
& Funk, 2012).  Still, moral distress can be the catalyst for positive change and help nurses 
achieve moral courage.   
There was a weak negative but not significant relationship between the Moral Distress 
and Professional Moral Courage scores, indicating that higher Moral Courage scores were not 
related to lower Moral Distress scores.  Fundamental to the moral distress argument is the 
perceived inability to act on one’s moral obligations and values (Whitehead et al., 2015).  
However, an important finding in this study was that nurses were able to take the moral action 
and set aside their own differences.  Sekerka et al (2009) suggested that moral agents or 
individuals who adhere to moral values are aware that their position, identity, and character may 
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be at risk.  However, moral agents manage their emotions and balance their desire to proceed 
with the action against other competing threats (Sekerka et al., 2009).  Moral courage was also 
manifested in examples of patient advocacy in the face of fear and retribution (Lachman, 2007a).   
In this study, a nurse in the outpatient setting refused to give the chemotherapy after 
reading the package insert because the risk for reaction was high in that patient but was not 
supported by the manager.  In a different case, the nurse called the legal department to support 
the written and verbal wishes for care that was communicated by the patient and healthcare 
surrogate.  However, the case escalated to a real danger, “the physician was upset and used 
physical force to communicate disapproval with the nurse.”  Outcomes of courage also include 
acting in the patient’s best interest by alleviating pain or suffering, communicating with patients 
and family openly, and collaborating with physicians effectively (Hawkins & Morse, 2014). 
Regardless of the actual or perceived threat, nurses who stand up and act accordingly 
when their moral principles are threatened demonstrate moral courage (Lachman, Murray, 
Iseminger, & Ganske, 2012).  Handling a delicate situation was described by the nurse who 
informed the attending physician of the patient's expressed wishes but the physician persisted in 
starting treatment.  “I initiated a consult to the Ethics Committee as I was acting as my patient's 
advocate.  I knew it was my role as a nurse to take the actions that I did.  For that, I am grateful 
that I was able to be this patient’s advocate.”   
Despite experiencing levels of moral distress, the nurse demonstrated support and respect 
for the patient’s decision-making and autonomy.  Patient autonomy was exemplified by one 
nurse who said, “it did not seem like much, but it was all I could do, explaining each physician’s 
role in her treatment and reassuring her that I had heard everything the doctors had said and 
could help her explain to family members due to arrive that evening, encouraging her to write 
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down questions as she thought of them so that she could be ready for the doctors when they came 
in the next morning.”  In this example, the nurse took an active role to ensure that the patient was 
well-informed to decide on a plan of care from a realistic set of options that aligned with the 
patient’s goals and preferences (Sherner, 2016).  Only one nurse reported that she was not able to 
take a moral stand due to the ethical climate in her office and fear of ramification.  Previous 
studies found a negative correlation between moral distress and ethical climate.  The ethical 
climate is defined as the organizational culture and processes that support open discussion and 
resolution of ethical decisions (Hamric & Blackhall, 2007).  The more ethically supportive the 
work environment the lower the moral distress, suggesting that the quality of the ethical climate, 
conflict resolution and support for staff are influenced by other factors that do not necessarily 
explain the differences in moral distress (Hamric, Borchers, & Epstein, 2012; Whitehead et al., 
2015).   
The uncertainty in prognostication often makes it difficult for physicians to discuss end 
of life options and to stop treatment (Barclay & Maher, 2010).  This view supports the current 
assumption that dynamics beyond nurses’ control were associated with the most moral distress.  
However, qualitative responses provided by several nurses in this study were reflective and they 
did not perceive themselves as passive bystanders.  A few respondents reported that the morally 
distressing experience gave them an opportunity to re-evaluate their own values and beliefs.  
Nurses practicing with moral courage know that addressing these issues is leadership in action 
(LaSala, & Bjarnason, 2010) and these qualities must be cultivated to show effectiveness.  This 
data will lead to instrument development that will better measure the issues for oncology nurses.  
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Moral Distress Residue 
In this study, moral distress residue manifested as guilt, anger, fear, emotional pain, and 
frustration.  For example, one nurse said it was difficult not to internalize anger and frustration 
toward the “decision-makers.”  A different nurse shared, “for me it was emotionally painful to 
watch a patient suffer from persistent pain, watch nursing staff suffer emotionally from watching 
a patient suffer and dealing with my own feelings of not advocating more for the patient.”  These 
remarks may support the idea that cumulative effects of unresolved moral distress result in moral 
distress residue (Webster & Baylis, 2000) which can negatively impact emotional responses and 
nurses’ practice.  These findings were similar and support previous studies that moral distress 
has negative consequences such as anger, suffering, sadness, grief, guilt, and stress (Gutierrez, 
2005; Wiegand & Funk, 2012).  
The quantitative results demonstrate that oncology nurses experienced moral distress 
residue.  Nurses who left a previous job (26%) and those who considered leaving (28%) reported 
statistically significantly higher mean Moral Distress levels than those who had not considered 
leaving.  The intent to leave a current job has important implications for nursing leadership.  In 
this study, oncology nurses (17%) who are currently considering leaving their jobs due to the 
way patient care is handled at their institutions have the highest Moral Distress mean scores and 
the lowest Professional Moral Courage scores.  Having left or considered leaving a past job was 
an indirect or proxy indicator of moral residue, but intent to leave a current position was more 
about current levels of moral distress (A. B. Hamric, personal communication, November 9, 
2014).  These findings were similar to and support those of previous studies (Allen et al., 2013; 
Cavaliere, Daly, Dowling, & Montgomery 2010; Corley, Elswick, Gorman, & Clor, 2001; 
Lazzarin, Biondi, & DiMauro, 2012; Maningo-Salinas, 2010; Sirilla, 2014).  As such, when 
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nurses experience unresolved moral distress, healthcare systems are impacted by the negative 
consequences, because nurses leave the profession or seek less stressful jobs (Ritenmeyer & 
Huffnan, 2009).  Regardless, attention must be given to job-related conditions in which moral 
distress occurs with a focus on interventions that support moral courage and lessen moral 
distress.  
Moral Agent Conceptual Framework 
The conceptual framework tested in this study confirmed that morally challenging 
situations (patients’ wishes not being heard, medically inappropriate or futile treatments, 
inadequate pain control, poor provider collaboration and communication, disregard or delays in 
discussing prognosis and DNR, false hope, time constraints, confidentiality, and inappropriate 
informed consent) preceded experiences of moral distress and moral courage.  The most 
challenging situation experienced by these nurses was associated with the patients’ wishes not 
being heard by the family and providers.  In general, work setting was a weak predictor of moral 
distress and total years working in oncology was a weak predictor of moral courage.  Nurse 
characteristics as predictors of moral distress and moral courage (such as education level, 
professional certification, End of Life Nursing Education) were not supported in the model and 
had no influence on Moral Distress and Professional Moral Courage scores, which suggests that 
other variables contribute to this phenomenon.   
Nurses with the highest levels of moral distress were more likely to experience moral 
distress residue with unresolved or repeated encounters of moral distress and leave a current job.  
It is not known whether an activity directed at building moral courage skills will improve moral 
courage or impact moral distress residue.  A pre-test, post-test design using the Professional 
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Moral Courage Scale could measure the impact of a moral courage training activity on moral 
courage over time.  The qualitative responses from this study can to refine the conceptual model 
and Professional Moral Courage Scale to use in future studies to evaluate moral courage in 
oncology nurses.  The qualitative question in this study did not address barriers to moral courage 
which should be identified and included in the model.   
Policy Implications 
Oncology nurses are important members of the interdisciplinary team.  Open 
communication and collaboration between physicians and other members of the team, including 
patients and their family members are fundamental to quality care and patient safety.  Emphasis 
on high quality care and delivery models that are patient-centered and adheres to the patient’s 
preferences must be grounded in moral courage and professionalism that recognizes and supports 
high standards of practice (Fasoli, 2010).  Nurses and healthcare administrators must align 
professional practice models with changes in system level processes that support and encourage 
a collaborative decision-making environment, rather than a paternalistic process that favors one-
sided decision-making and ignores concerns (Pavlish et al., 2015).   
Given rising healthcare costs and evidence about the financial burdens experienced by 
cancer patients (Donley & Danis, 2011), it is reasonable to balance healthcare costs with 
thoughtful considerations that respect patients’ choices.  Offering patients the choice of less 
expensive palliative care rather than unwanted treatments may also help to reduce morally 
incongruent care.  Discussing personal care preferences with cancer patients will ensure that 




Furthermore, nurses are ready to leave their job when situations contributing to moral 
distress do not get resolved and they cannot act on their professional judgement.  The link 
between moral distress and leaving a job supports the need to minimize moral distress to 
improve nurse retention (Whitehead et al 2015).   
Oncology nurses who do exhibit moral courage also need support from nursing 
leadership.  Nurse educators and nurse leaders must begin to cultivate moral courage and educate 
nurses and future nurses the competencies to recognize and effectively deal with moral distress 
in the work setting without negative ramifications.  Moral distress does not have to be an 
occupational hazard of healthcare.  Healthcare leaders must create an interdisciplinary bioethics 
competency-based curriculum for nurses, physicians, and other healthcare professionals to assure 
a stable work force and safe ethical environment that supports open dialog, moral courage, and 
problem resolution.   
Nursing Implications and Research Recommendations 
Few nurses in this study activated a consult to the ethics committee.  Nurses’ stories 
concerning their experiences with ethics consultations or committees may suggest that the 
process was unfamiliar to them and some nurses had a negative experience (Pelton, 
Bohnenkamp, Reed, & Rishel, 2015).  Nurses who have taken ethics content in their nursing 
programs correctly identify morally troubling situations but may feel unsupported in their work 
settings, which adds to the moral distress.  Validate that nurses are familiar with the ANA Nurses 
Code of Ethics (ANA, 2015).  Establish that nurses know and understand the process for 
obtaining an ethics referral to ensure timely referrals.  Ensure that the Ethics Group is 
represented by staff nurses and visible on oncology units where these situations are likely to 
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occur.  Create a proactive process to identify and discuss difficult cases on the unit to normalize 
the experience and show support for both nurses and providers.   
Train physician-nurse champions in conflict resolution in both the inpatient and 
outpatient settings to address ethical concerns toward improving the ethical climate.  This dyad 
could launch a weekly or monthly journal club using current articles from the oncology and 
bioethics literature to stimulate open discussion, integrate evidence based practice and promote 
positive change.  Create a support group or one-on-one mentoring program where more 
experienced nurses in the outpatient setting can provide newer nurses a safe environment to learn 
leadership and moral courage skills to ensure that patients’ preferences and voices are heard.  
Identifying barriers to moral courage and testing the predictive ability is needed so that strategies 
and interventions can test moral courage outcomes.  The model could be used in other care 
settings as a framework to test different interventions and relationships.  For example, the box 
representing nurse characteristics in the framework could be replaced with an educational 
intervention using control and experimental groups to test the intervention and relationship or 
influence on moral distress and moral courage.  The model and recommendations discussed in 
these finding should be tested in future studies.  
Nurse leaders, quality and safety councils, risk managers, and administrators must 
acknowledge that moral distress is present in the work setting and be proactive by including 
training and skilled conversations regarding end of life care, code status and advance care 
planning into the nurses’ orientation to the unit and annual competencies.  Nurses must also be 
aware of their actions and preserve, protect, and support rights of the patients even if they 
disagree (ANA, 2015).  Further efforts are needed to educate the public about appropriate care to 
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safeguard the patient from harmful or undesired treatments that may not be medically 
appropriate in advance stages of illness and increase suffering at end of life.   
Studies are needed to test different approaches that mitigate moral distress and bolster 
moral courage.  Certain situations contributing to moral distress, such as lack of time to discuss 
patient goals, violation of patient confidentiality, and inappropriate informed consent are 
problematic and require immediate attention and resolution.  Being honest without taking away 
hope (Pavlish, Brown-Saltzman, Jakel & Fine, 2014) requires skill.  Regardless, nurses should 
expect to have goals of care conversations with patients about their values and preferences, 
which then need to be conveyed to and respected by members of the healthcare team.  To start, 
develop quarterly ethics case reviews and presentations derived from practice that focus on 
recognizing, analyzing, and taking action.  The case reviews and presentations must include 
practical and interactive bioethics, utilizing role playing and problem-solving strategies.  
Edmonson (2015) tested a pretest-posttest intervention to develop moral courage in 16 nurse 
leaders using the Balance Experiential Inquiry (BEI) framework and past experiences for 
reflective learning to gain an understanding of what promoted or curtailed participants’ ability to 
respond to ethical issues.  BEI incorporates an andragogic philosophy of adult learning, in which 
participants who experienced an ethical dilemma reflected on the experience, reasoned abstractly 
about the experience, and then acted and experimented with newly acquired behaviors 
(Edmonson, 2015; Sekerka, Godwin, & Charnigo, 2012).   
Another strategy is monthly journal club activities using literature and evidence based 
approaches that can be incorporated into the unit or outpatient learning activities to encourage 
interdisciplinary team participation and collaboration between nurses and providers that nurture 
moral courage.  Nurse leaders and nurse educators will need to develop expertise in the concepts 
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of moral literacy and best practices for teaching moral courage so that current and future nurses 
are able to contribute to their ethical climate in a confident and healthy manner (Edmonson, 
2015).   
Although healthcare organizations have begun to undertake changes in policies and 
practices to empower healthcare professionals with the goal of improving communication and 
collaboration (Browning, 2013), role-playing morally challenging clinical situations and moral 
courage in health care settings will provide greater opportunities to practice effective team 
communication and interdisciplinary education on these topics to enhance the learning 
experience for staff and students that build team collaboration and moral courage.  Assertiveness 
training to improve nurse-physician communication (Curtis, Tzannes, & Rudge, 2011) and role 
playing interventions are likely to normalize levels of moral distress and could be tested using an 
experimental design.  Work settings that focus on improving the ethical climate are likely to 
lessen the experience of moral distress and help to maintain a stable workforce and nurse 
retention.  In addition, this study should be replicated and the moral courage scale should be 
tested in a different population of nurses.  Further study or improved measurement is needed to 
uncover the relationships among such variables.  Thus, future work should go beyond this.  For 
example, there are likely personality traits that predispose individuals to experience distress (like 
neuroticism) and also to show moral courage (conscientiousness).  
Limitations 
Threats to validity affect the generalizability of the findings to other samples, settings and 
practice (Polit & Beck, 2012).  This study has limitations to both internal and external validity.  
The convenience sample recruited for this study was drawn from the Oncology Nursing Society 
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national membership, representing two regions and was not a random sample.  Although the 
online survey was electronically mailed to over 2,400 members, the response rate was 11%, 
which could suggest that the topic was divisive or not relevant to the recipient.  Additionally, 
self-selection raises potential for bias.  A higher number of nurses with more than an Associate’s 
degree participated in the study and may suggest that nurses with professional affiliation in ONS 
tend to have advanced degrees which was higher than similar studies.  Nevertheless, e-mail and 
online survey response rates varied from 8% to 11% (Hunter, 2012) and often fall far below 30% 
(Sheehan, 2008).  A disadvantage of this recruitment method is that only members of the 
national organization are invited to participate, therefore, generalizability to other settings is a 
limitation.   
Another limitation is that the MDS-R instrument has not been tested in the outpatient 
specialty clinical areas, such as outpatient oncology (Hamric et al., 2012) and may not have 
captured the essence of situations relevant to participants in that environment.  However, 
context-specific situations of moral distress found in this study could be used to develop an 
appropriate measure for clinicians in the outpatient oncology setting.  At the time of this study, 
no studies were found that included use of the PMCS in an oncology nursing sample.  Although 
the instrument demonstrated good internal consistency with a Cronbach alpha of .89, the PMCS 
scores ranged from 4.47 to 7.0 points with a mean score of 6.10 which may suggest that the scale 
has a high social desirability bias.  Respondents may have answered questions in a manner that 
was viewed favorably by others.  The PMCS scores in the study are also very high which may 
indicate a ceiling effect which makes discrimination among subjects at the top end of the scale 
difficult.  The study should be replicated in a different sample of oncology nurses.  Additionally, 
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the self-reported moral courage in the qualitative portion was not matched to the same 
participant’s moral distress, which could be evaluated in a future study.   
Gender and diversity of the sample were also limitations, representing 3% males, 2% 
Asian, 4% Hispanic, and 13% African Americans.  Because of the small group sizes, differences 
between the groups could not be determined.  More males and higher participation among 
diverse ethnic groups are needed to be more in line with population diversity in future studies as 
their perspectives on moral distress and moral courage are missing in the literature.  According to 
a 2014 survey by the Health Resources and Services Administration (HRSA), the nursing 
workforce for males represents 9%, reflecting a 12.5% increase since 2000 (American Nurses 
Association, 2014).   
Another limitation was that the qualitative question did not elicit barriers to moral 
courage, which would have been important to assess.  It was just by chance that one person 
answered in a way that addressed this.  Additionally, Schilling's pragmatic method used in the 
qualitative data analysis does not as much encourage expansion of conceptual development it is 
more confirmatory. 
Conclusion 
The current study reveals that moral distress among nurses is present in the oncology 
setting.  Nurses in inpatient settings had higher moral distress levels than in outpatient settings.  
However, nurses in outpatient settings identified situations that are pertinent to the outpatient 
setting such as insufficient informed consent and pressuring patients to start or continue therapies 
that warrant future investigation.  Despite levels of moral distress, oncology nurses displayed 
moral courage by supporting the patient, risk taking, advocacy, enlarging the circle for decision 
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making, empowering the patient, fighting for the patient in the face of consequences in a 
complex system, sharing information and truth telling.  Moral courage is a learned quality of 
moral character that influences individuals to do the right thing (American Nurses Association, 
2015).  Therefore, ongoing education in ethics derived from clinical practice provides a 
foundation for nurses to create, maintain, and contribute to morally acceptable environments that 
enable nurses to be morally courageous (ANA, 2015).  Nonetheless, for moral courage to 
flourish, nurses must be supported by a moral environment that enables open communication, 
collaboration, respect, and transparency (American Association Nurses, 2015).  Nurses are 
important contributors to their work environment, and transformation of the practice 
environment not only requires safe quality care, but must assure that the patients’ voices are 
heard.  Nurses should expect to participate in honest dialog with patients, families and members 
of the healthcare team in order to align with the patient’s preferences, realistic treatment goals, 
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APPENDIX C: MORAL DISTRESS SCALE-R (MDS-R)  




Moral Distress Scale Revised – Adult 
 
Moral distress occurs when professionals cannot carry out what they believe to be ethically appropriate 
actions because of internal or external constraints. The following situations occur in clinical practice.  If you have 
experienced these situations they may or may not have been morally distressing to you.  Please indicate how 
frequently you experience each item described and how disturbing the experience is for you. If you have never 
experienced a particular situation, select “0” (never) for frequency.  Even if you have not experienced a situation, 
please indicate how disturbed you would be if it occurred in your practice.  Note that you will respond to each item 
by checking the appropriate column for two dimensions:  Frequency and Level of Disturbance. 
 






Never  Very  frequently                                                                      None Great extent
1 1 2 3 4 0 1 2 3 4 
1. Provide less than optimal care due to pressures from 
administrators or insurers to reduce costs. 
          
2. Witness healthcare providers giving “false hope” to a 
patient or family. 
          
3.  Follow the family’s wishes to continue life support 
even though I believe it is not in the best interest of the 
patient. 
          
4.  Initiate extensive life-saving actions when I think 
they only prolong death. 
          
5.  Follow the family’s request not to discuss death with 
a dying patient who asks about dying. 
          
6.  Carry out the physician’s orders for what I consider to 
be unnecessary tests and treatments. 
          
7.  Continue to participate in care for a hopelessly ill 
person who is being sustained on a ventilator, when no 
one will make a decision to withdraw support. 
          
8.  Avoid taking action when I learn that a physician or 
nurse colleague has made a medical error and does not 
report it. 
          
9.  Assist a physician who, in my opinion, is providing 
incompetent care. 
         
 
10. Be required to care for patients I don’t feel qualified 
to care for.  
         
11.  Witness medical students perform painful 
procedures on patients solely to increase their skill. 







Never  Very  frequently                                                                      None Great extent
1 1 2 3 4 0 1 2 3 4 
12.  Provide care that does not relieve the patient’s 
suffering because the physician fears that increasing the 
dose of pain medication will cause death. 
          
13.  Follow the physician’s request not to discuss the 
patient’s prognosis with the patient or family. 
          
14.  Increase the dose of sedatives/opiates for an 
unconscious patient that I believe could hasten the 
patient’s death. 
          
15.  Take no action about an observed ethical issue 
because the involved staff member or someone in a 
position of authority requested that I do nothing. 
          
16.  Follow the family’s wishes for the patient’s care 
when I do not agree with them, but do so because of 
fears of a lawsuit. 
        
 
 
17.  Work with nurses or other healthcare providers who 
are not as competent as the patient care requires. 
          
18.  Witness diminished patient care quality due to poor 
team communication. 
          
19.  Ignore situations in which patients have not been 
given adequate information to insure informed consent. 
          
20. Watch patient care suffer because of a lack of 
provider continuity. 
          
21. Work with levels of nurse or other care provider 
staffing that I consider unsafe. 
          
If there are other situations in which you have felt moral 
distress, please write them and score them here: 
          
           
           
 
Have you ever left or considered quitting a clinical position because of your moral distress with the way 
patient care was handled at your institution? 
No, I’ve never considered quitting or left a position ______ 
Yes, I considered quitting but did not leave ______ 
Yes, I left a position ______ 
Are you considering leaving your position now?   Yes ___ No ___  
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Sekerka et al. Professional Moral Courage Scale 
 
Evaluate the statements as they pertain to you at work, on a scale from 1 (never true) to 7 
(always true). 
 
Never   Sometimes       Always 
1 2 3 4 5 6 7 
Theme 1    
_____ 1. I am the type of person who is unfailing when it comes to doing the right thing at work. 
_____ 2. When I do my job I regularly take additional measures to ensure my actions reduce 
harms to others. 
_____ 3. My work associates would describe me as someone who is always working to achieve 
ethical performance, making every effort to be honorable in all my actions.  
 
Theme 2  
_____ 4. I am the type of person who uses a guiding set of principles from the organization as 
when I make ethical decisions on the job. 
_____ 5. No matter what, I consider how both my organization’s values and my personal values 
apply to the situation before making decisions. 
_____ 6. When making decisions I often consider how my role in the organization, my boss 
(supervisor or leader), and my upbringing must be applied to any final action.  
 
Theme 3  
_____ 7. When I encounter an ethical challenge I take it on with moral action, regardless of how 
it may pose a negative impact on how others see me. 
_____ 8. I hold my ground on moral matters, even if there are opposing social pressures.*  
_____ 9. I act morally even if it puts me in an uncomfortable position with my superiors.*  
 
Theme 4  
_____ 10. My coworkers would say that when I do my job I do more than follow the regulations, 
I do everything I can to ensure actions are morally sound. 
_____ 11. When I go about my daily tasks I make sure to comply with the rules, but also look to 
understand their intent, to ensure that this is being accomplished as well. 
_____ 12. It is important that I go beyond the legal requirements but seek to accomplish tasks 
with ethical action as well.  
 
Theme 5  
_____ 13. It is important for me to use prudential judgment in making decisions at work. 
_____ 14. I think about my motives when achieving the mission, to ensure they are based upon 
moral ends. 










Nurse Demographic and Characteristics 
 
To help me interpret your responses, please provide the following information. As with your answers to the 
other portions of this survey, your responses will be kept confidential. 
 
1) What is your age? _____________ Years 
 
2) Gender: ______________ 
 
3) What is your racial or ethnic background? ___________________________________ 
 
4) What is your highest education level in nursing? 
Diploma in nursing __ 
Associate degree in nursing __ 
Bachelor degree in nursing __ 
Master’s degree in nursing __ 
Doctoral degree in nursing __ 
 
5) What is your current employment status? 
Full-time (36+ hrs/week) _____ 
Part-time ____ 
Per Diem nurse ____ 
Agency nurse ____ 
Traveler nurse ____ 
Retired (more than 3 months) Yes ____    No _____ 
 
6) What is your current work setting? 
Inpatient oncology unit    ___ 
Outpatient oncology unit ____ 
Other______________________________________ 
 
7) Total number of years working as a registered nurse. ______________years 
 
8) Total number of years working as an oncology nurse. ________years 
 
9) Are you certified in oncology nursing?   
Yes _____   No ____ 
10) Have you taken End of Life and Palliative Nursing Education (ELNEC) course?    
 Yes _____   No ____  
11) Which of the following statements best describes your highest basic education in health care ethics? 
Ethics content integrated throughout nursing program of study ___ 
Separate Ethics Course ___ 
No ethics content ___ 
12) Have you taken any continuing education courses in health care ethics? 
Yes ____ No ____ 
13)  Have you ever requested or participated in a consultation with the ethics committee to deal with a morally 
distressing clinical situation? 
Yes ____ No ___   
14) If you experienced a morally challenging situation describe how you took a stand for your patient; what was the 




APPENDIX F:  ABREVIATED E-MAIL ANNOUCEMENT TO  




Abbreviated Email Announcement 
I am asking you to assist in an online survey, being conducted as part of a 
research project under the supervision of Dr. Norma Conner and Dr. Susan Chase at the 
University of Central Florida in fulfillment of my doctoral degree (PhD) requirements.  
You are being requested to contribute because you have been identified as an oncology 
nurse with adult patient oncology experience.  
The purpose of the study is to obtain information regarding Oncology Nurses’ 
perceived distress and identify what actions are taken by nurses in clinical situations 
when caring for patients with serious illness and terminal conditions.   By participating, 
you will be helping to provide insight into this essential undertaking.  The results will be 
presented at nursing conferences and submitted for publication in oncology journals. 
 The survey is anonymous; no names or personal identifying data is necessary, 
and we will not divulge information that will distinguish you as a participant.  If you 
choose to participate, approximately 15 minutes of your time is required.  Involvement is 
voluntary and responses are confidential.  You should try to answer all the questions.  
However, you do not have to answer a question you are unsure about or that makes you 
feel uncomfortable.  To complete the online survey please use this link 
https://ucf.qualtrics.com/ControlPanel/?ClientAction=ChangePage&s=MySurveysSectio
n&ss=&sss= or copy and paste the URL into your internet browser.  Completion of the 
survey will serve as consent.   
 
Sincerely, 
Lolita Melhado, MSN, ARNP, FNP-BC 










EXPLANATION OF RESEARCH 
Title of Project: Evaluating Moral Distress, Moral Residue, and Moral Courage in the Oncology 
Nurses     
Principal Investigator: Lolita Melhado, MSN, ARNP, FNP-BC  
 
Other Investigators:   N/A 
 
Faculty Supervisor:  Susan K. Chase, EdD, RN, FNP-BC and Norma E. Conner, PhD, RN 
You are being invited to take part in a research study because you have been identified as an 
oncology nurse with adult patient oncology experience.  ONS did not contribute to the 
development of this survey or research study.  Sharing of this request does not imply ONS’s 
involvement or endorsement of the survey or research study. All research on human volunteers 
has been reviewed by an Institutional Review Board. Participation in this survey constitutes your 
informed consent.  Whether you take part is up to you. 
 
The purpose of this study is twofold: (1) the researcher will examine the relationship between moral 
distress, moral residue, and moral courage in oncology nurses working in the adult inpatient and 
outpatient settings, and (2) the researcher will identify which oncology nurse characteristics are 
predictors of moral distress and moral courage; and specifically what oncology nurse actions 
indicate moral courage. 
Participants who choose to participate in this anonymous on-line survey will access the 
study link to the Qualtrics on-line Survey. The participant may access the on-line survey from his or 
her individual computer or smart phone and will be prompted to read and accept this consent. No 
names or identifying coding will link the subject to the survey. Completion of the on-line survey 
will serve as written consent.  
The on-line survey consists of three parts. The first part of the survey consists of 
demographic data. You will complete 13 demographic items consisting of brief questions (i.e., age, 
gender, level of education, total years education, etc) and one open-ended question intended to 
ascertain what action were taken by the nurse to demonstrate moral courage. Next, you will read the 
instructions for the Moral Distress Scale-R (MDS-R) and respond to 21 items indicating the level of 
frequency and level of disturbance experienced in each clinical situation. The items are measured on 
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two dimensions as 0 – 4 (none to very frequent) and 0-4 (no disturbance to great disturbance). You 
may also write in two additional clinical situations if they choose and rate the level of frequency and 
disturbance. Additionally the scale contains two closed ended questions (yes or no responses) to 
evaluate moral residue. The final scale, Moral Courage Scale is a 15-item 7 point scale. 
Respondents are instructed to read the instructions and respond to each item ranging from 1 (never) 
to 7 (always).   
The time needed to complete the Qualtrics on-line Survey is 15 minutes. Data is collected a 
single time. The time in the study ends when the survey is completed.  
You must be 18 years of age or older to take part in this research study. 
  
Study contact for questions about the study or to report a problem: If you have 
questions, concerns, or complaints: Lolita Melhado at 239-314-4126 or 
lolita.melhado@knights.ucf.edu. You may also contact my faculty supervisors: Dr. Susan chase 
(407-823-6274; susan.chase@ucf.edu) or Dr. Norma Conner (407-823-2630; 
norma.conner@ucf.edu).  
IRB contact about your rights in the study or to report a complaint:    Research at the 
University of Central Florida involving human participants is carried out under the oversight of the 
Institutional Review Board (UCF IRB). This research has been reviewed and approved by the IRB. 
For information about the rights of people who take part in research, please contact: Institutional 
Review Board, University of Central Florida, Office of Research & Commercialization, 12201 









From: Ann B Hamric [mailto:abhamric@vcu.edu]  
Sent: Tuesday, February 26, 2013 11:03 PM 
To: Melhado, Lolita 
Cc: Alison Crehore 
Subject: Re: Permission to use MDS-R 
Dear Ms. Melhado, 
 
Thank you for your interest in the Moral Distress Scale – Revised (MDS-R).  There are 
six versions of this scale: nurse, physician and other healthcare professional versions for adult 
settings (including ICUs and other inpatient units), and parallel versions for healthcare providers 
in pediatric settings.  
 
I am happy to grant permission to use any of the MDS-R scales, but require agreement to 
the following condition:  Individuals wishing to use the MDS-R must agree to share their 
data with Drs. Hamric and Corley in an SPSS file in order to further the psychometric 
testing of the instrument. 
 
If you agree to adhere to this condition for use, I am happy to give you permission to use 
the scales. I have attached the adult nurse version.  Let me know if you are interested in the nurse 
pediatric version as well. If you decide to change items for particular specialty purposes, Dr. 
Corley and I request that you keep us informed of the changes you make and the results you 
obtain. 
    




Ann B. Hamric, PhD, RN, FAAN 
Associate Dean of Academic Programs 
Professor, School of Nursing 
Virginia Commonwealth University 
1100 East Leigh Street, Room 4009b 
P.O. Box 980567 
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Coding Category Final Categories and Process of Analysis 
Content category Themes Taking a Stand/Moral Courage Example 
Moral agency – a predisposition 
toward moral behavior and 
possessing a persistence of will to 
engage as a moral agent (Sekerka, 































 Importance of advocating; supporting patient autonomy. Supporting the patient was 
the right thing to do. The patient was my first concern. 
 Ensuring she received the very best care possible; to help the other staff appreciate 
that this was her will and her right. 
 Supporting patient's decision. 
 Advocating and supporting patient autonomy. 
 It did not seem like much, but it was all I could do.  Explaining each physician's role 
in her treatment and reassuring her that I had heard everything the doctors had said 
and could help her explain to family members due to arrive that evening. Encouraging 
her to write down questions as she thought of them so she could be ready for the 
doctors when they came in the next morning. 
 Although this was a very tragic situation and very stressful for the staff caring for the 
mother (unresponsive) as the clinical specialist it was my job to ensure she received 
the very best care possible and help the other staff appreciate that this was her will and 
her right. 
 Allowing the patient to express his feelings and make a decision by himself. 
Respecting the decision. 
 
 Confronting physician responsible for providing unwanted continuing care at end of 
life; I was influenced by my role as patient advocate and my refusal to participate in 
unethical treatment 
 Confronting a physician for not making a patient a no code 
 Reporting the concern to IRB. 
 Supporting patient's end of life decisions, stopping treatment although family was 
completely against this decision 
 
 Fighting for my patient’s best. Informing family of current status, level of discomfort, 
providing excellent care and comfort to the patients.  
 Allowing the patient to participate in decisions; listening to their voice; working my 
best to communicate to the physician(s) current status; assessment. Doing everything 
possible for my patients in caring and respectful manner. 
 Explaining to the patient that she has a right to dictate her care, if she didn't want this 
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Content category Themes Taking a Stand/Moral Courage Example 
type of treatment, she didn't have to take it. The patient didn't want it; walked her back 
to the physician side so she can talk to him.  I believe patients have a right to decide 
what kind of care they receive. That is what made me take action with this patient, or 
any patient. 
 Advocating for my patient is my number one priority. 
 
Multiple values – the ability to 
draw on multiple value sets in 
moral decision making and to 
effectively sort out and determine 
what needs to be exercised, and to 
hold firm to beliefs despite 
external concerns or demands 
(Sekerka et al., 2009)  
Enlarging the Circle 





























            Beyond Personal  
            Values 
 Supporting the patient decision.  I contacted the patient’s medical doctor who agreed 
to take over the patient’s end of life care. 
 We ended up consulting a physician who was of the patient's nationality to speak with 
family, then with patient, and the patient gave informed consent/ received the 
treatment that he needed with full understanding 
 Requesting an ethics consult and we were able to get an oncologist on board who 
ordered appropriate pain medication for the patient 
 Recommending that the family get a 2nd opinion from another Med Oncologist.  They 
agreed----they simply needed affirmation that what they suspected was true. 
 Spending my own time researching where he had been who he had been with and over 
a period of days was able to identify significant others for him.  They were able to 
come see him and contact his children before he was taken off life support. I chose to 
give it my best effort so he wasn't alone and then lost. 
 Recommending ethics committee involvement and tried to persuade family that 
patient's pain was real and required analgesics that would be given cautiously. 
Educated family on addiction and on negative impact of uncontrolled pain on patients. 
 Informing the Attending MD of patient's expressed wishes.  MD insisted on starting 
treatment.  I initiated a consult to Ethics Committee as I was acting as my patient's 
advocate.  I knew it was my role as a nurse to take the actions that I did.  For that, I 
am grateful that I was able to be this man's advocate 
 Meeting with the physician; supporting the patient’s choice to decline treatment. 
Stopping the chemotherapy authorization until this was resolved 
 Having a care conference with social worker, case manager, medical doctor, sisters, 
husband and the patient. Supporting the patient by sharing her story, her dreams of 
spending time with her girls/husband at home and not in a hospital 
 Corralling the various medical staff and nursing staff caring for him, plus social 
service and requested an Ethics Committee meeting. The recommendation was to 
keep him in the US in a facility that could safely care for him and attempt to get a visa 
for his mother or a sibling. 
 
 Putting my personal beliefs aside and encouraging the family to communicate.  
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 Respecting the patients’ decision even if I don’t agree. 
 Spending time with patient, educating her on disease type and all possible treatment 
options and possible side effects.  Felt she was making an educated decision and 
although I personally did not agree with her, I felt it was her right to make this 
decision 
 
 Wanting the patient’s wishes to be met not family's wishes 
 Encouraging her to talk to her family and her doctor about what she wanted, and 
reminded her it was her choice as to how much she wanted to undertake. I talked with 
her about it first because she brought it up, she seemed frail and tired and scared, and I 
sensed she might not have made her own feelings clear to her family. She ended up 
going through treatment 
 
 Agreeing and participating in a family conference with the patient, explaining there 
were no treatments available that could provide cure for this disease in the setting of 
failing a bone marrow transplant. I believed I empowered the patient to make the 
decision he desired. 
 Asking "which of you want to see your loved one die in pain and suffering" This after 
days of explaining the dying process.  I told them that death was imminent and it was 
not a matter of the choice for stratification or full code, it was a choice of how she 
should die, with or without pain. After days of cajoling, I could no longer feel for the 
family because it was my responsibility to advocate for the pt 
 
Endures threat – facing an ethical 
and moral difficulty, both 
perceived and real danger or 
threat, with endurance (Sekerka et 
al., 2009) 
Fighting for my 
Patient in Face of 
Consequences in a 












 Refusing to give therapy and not getting the patient’s consent.  I went to the physician 
and his nurse and stated the patient needed to come back to an exam room to discuss 
treatment side effects prior to infusion. The physician was trying to push to continue 
d/t time constraints and I pushed back and said it wasn't appropriate. 
 Speaking with a more senior physician on staff and he arranged for the infant to spend 
a few hours with the young mother on the unit. 
 Calling the Doctor and told him she refused and he said I was crazy, she did not even 
know what was going on. I did not insert the tube and got the head of Ethics to come 
and he agreed that patient was refusing the feeding tube. 
 Approaching a physician who continued to aggressively treat a terminally ill patient. 
Encouraged palliative care and dialogue with family. Dr. was not happy. My 
experience and strong patient advocate philosophy helped. 
 Calling the physician and refusing to give drugs. Physician called administration. I 
was supported by my nurse manager in the a.m. 
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 Initiating an Ethics panel meeting and the decision to proceed with disconnecting the 
ventilator was made.  The physician volunteered to come in and turn off the machine 
himself in view of the stance by the staff (they said they would quit the job rather than 
follow the order). 
 Calling Legal counsel as this was an emergent situation. I wanted to support the 
written and verbal desires for care communicated by both the patient (when able) and 
the wife as the durable power of attorney.  Legal consult done with physician. Patient 
was not placed on ventilator. However, the physician came by my office and 
physically knocked office door off hinges wanting to know where I was. I was not 
present. Security was called by my office mate. Physician was escorted out of 
hospital. 
 Contacting legal department to come to discuss situation with patient's durable power 
of attorney. Dr. was instructed to abide by the wishes of patient/patient's durable 
power of attorney 
 
 Taking a deep breath, praying and answering according to patients conditions and 
needs 
 
Goes beyond compliance – one 
who not only considers the rules, 
but reflects on their purpose, goes 
beyond compliance-based 
measures to consider what is 
right, just, and appropriate 
(Sekerka et al., 2009) 
Sharing Information: 



















 Collaborating with our SW, the other nurse, the NP in our palliative care division, and 
the physician. I'm usually quick on my feet, but this was delicate: didn't need the 
family getting into an uproar, but at the same time, there was no reason to hide this 
diagnosis! If the patient had flat-out said "I don't want to know. Just treat me." fine. 
But he hadn't. 
 Talking honestly about her wishes, what she wanted and how she felt about going to 
the in-patient Hospice facility.  What was going through my head was how not 
terminal she looked.  (I have had loads of experience with terminal patients and this 
was not the feeling I was getting from her.)  I asked her if she had spoken to the 
covering medical oncologist. We talked and laughed and cried that afternoon/evening.  
Finally I asked her frankly, "what do you want to do?  Do you have any desire to try 
the chemotherapy again?"  I mentioned that either decision was hers, but if she wanted 
me to, I would call her medical oncologist and see if we could try one more round of 
treatment. I would do whatever it took to make her comfortable and peaceful. I also 
set in motion a lot of very upset administrators, nurses and supervisors who called me 
on the carpet for interrupting what was their plan to transfer her to the in-patient 
Hospice.  I argued that I was advocating for my patient, whom I knew very well and 
did not feel she was entirely hospice appropriate at this time.  I very nearly lost my job 
for going over the heads of the doctors, charge nurse and supervisor, but I did not 
back off advocating for her and I had given her the option of proceeding to hospice 
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care or trying a drug that had worked well for her in the past. I went with my 
experience and instinct, as it has served me well over my oncology nursing. 
 I sat down with him and asked him why he wanted to continue with therapy and what 
he expected to achieve with doing so.  The patient had the understanding that he could 
be cured.  I gently explained that the goal of therapy in his condition was palliation 
but if receiving therapy caused him more distress and decreased QOL he may want to 
consider forgoing therapy. The patient started to cry and definitely did not want 
therapy. I explained to his MD the patient's understanding. The physician's response 
to me was that he had been told! 
 
 Telling the physician as nicely as I could that I had his number and I knew he was on 
call the weekend and I was working all weekend and I would be calling on an hourly 
basis to continue to advocate for the patient who was moaning and writhing in the bed 
but not awake enough to tell me his pain level. 
 I found myself coming between my patient and administration and standing up to 
administration to allow my patient to come to terms with this very grave condition. 
They backed off. 
 
Moral Goal – a drive for task 
accomplishment that includes the 
use of virtues (e.g., prudence, 
honesty, and justice) throughout 
the decision making process to 
achieve a virtuous outcome 
(Sekerka et al., 2009) 
Truth Telling 
Protecting my Patient 
 Discussing with the patients their thoughts on what they wished for their care if they 
were to not recover from their disease and if they suddenly stopped breathing. I 
explained to the patient normally in the situation of a patient that becomes 
unresponsive it is protocol to begin CPR and in the event the patient did not breathe 
on their own they would be intubated, and hooked up to a breathing machine to keep 
them alive. I took a stand for my patient helping them discuss what their end of life 
wishes were. 
 I was very honest and candid with them and suggested some questions for them to ask 
the physician team. 
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Date: March 16, 2016          
Time: 1:30 pm 
Room: 328 
Title:  Evaluating Moral Distress, Moral Distress Residue and Moral Courage in Oncology Nurses 
Purpose:  To examine relationships between moral distress, moral distress residue, and moral courage and to 
determine which nurse characteristics are predictive of moral distress and moral courage. 
Methods: The study used a mixed methods cross-sectional correlation design and qualitative content analysis to 
investigate oncology nurses’ characteristics and relationships between moral distress, moral distress residue, and 
moral courage.  A convenience sample of 187 oncology nurses working in inpatient and outpatient settings was 
recruited through the national Oncology Nursing Society in the Southeastern United States.  A power analysis 
determined a sample of 159 subjects was required to detect statistical significance. Hamric’s 21-item Moral Distress 
Scale-Revised (MDS-R) and Sekerka et al. 15-item Professional Moral Courage Scale (PMCS) supplemented with 
written examples of moral courage were used for data collection.  Descriptive statistics, independent-samples t test, 
Pearson correlation, ANOVA, and multiple regressions analyses were used to evaluate data. 
Findings: MDS-R scores were not predictive of PMCS scores. No statistically significant differences were found 
between nurses’ characteristics (age, education level, certification, ELNEC training) and MDS-R.  Though nurses 
with a BSN had higher Moral Distress scores compared with other levels of education, none were predictors of 
MDS-R. ANOVA results indicate a marginal but not significant difference of the MDS-R score among the nurses 
with different basic ethics education (p = .067).  Nurses working in adult inpatient settings had significantly higher 
MDS-R than those in outpatient settings.  Nurses who had moral distress residue by virtue of leaving a previous job 
(26%) and those who considered leaving (28%) reported statistically significantly higher mean Moral Distress levels 
than those who had not considered leaving.  Nurses (17%) currently considering leaving their jobs due to the way 
patient care was handled at their institutions had the highest Moral Distress mean scores and the lowest Professional 
Moral Courage scores. Work setting and having left a previous job were weak predictors of MDS-R, accounting for 
11.6% of the moral distress score variance (p = .013) compared with 4.4% when work setting was a single predictor 
(p = .014).  Total years’ oncology experience was a weak predictor of PMCS, accounting for 2.5% or an 
inconsequential amount of the variance (p = .043).   Moral courage was displayed in major areas of supporting the 
patient, risk taking, advocacy, enlarging the circle for decision-making, putting aside personal beliefs, respecting 
patient autonomy, empowering the patient, fighting for the patient in face of consequences in a complex system, 
sharing information, getting to the meaning, handling tricky situations, protecting the patient and truth-telling 
Discussion/Implication: Despite experiencing levels of moral distress, oncology nurses demonstrate support and 
respect for patients’ decision-making and autonomy.  Ethics education derived from clinical practice can provide an 
opportunity for open discussion for nurses to create and maintain morally acceptable work environments that enable 
them to be morally courageous.   This research underscores the presence of moral distress and moral distress residue 
among oncology nurses and the importance of finding ways to lessen moral distress and strengthen moral courage in 
nurses. 
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